





Osteogenic Marker Expression in a Grafted 





















Methods and Materials: First,	 second	 and	 third	 premolars	 were	 extracted	 from	 30	
sheep.	The	socket	was	either	non‑grafted	for	spontaneous	healing	(control)	or	grafted	
using	 Bio‑Oss®	 and	 Bio‑Gide®	 (test).	 After	 4‑,	 8‑	 and	 16‑weeks	 the	 sheep	 were	
euthanised	 and	 tissue	 samples	 collected.	 Histological	 analysis	 was	 undertaken	 and	






associated	 staining	 in	 the	 test	 group	 at	 8‑	 and	 16‑weeks.	 Strong	 staining	 of	 RANKL	
associated	with	osteoblasts	and	osteoclasts	was	found	in	both	groups	at	all	time	points.	
Initial	 strong	 OPG	 staining	 localised	 to	 the	 connective	 tissues	 decreased	 over	 time.	









factor	 for	 osteoblast	 differentiation	 MSX2	 or	 the	 ECM	 markers	 Col1A1	 or	 TIMP3.	
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Chapter 1 Introduction and Literature Review 
 




teeth	 (Ministry	 of	 Health,	 2010).	 Tooth	 loss	 has	 negative	 impacts	 on	 masticatory	















in	 various	 animal	 models	 (Accorsi‑Mendonça	 et	 al.,	 2008;	 Liu	 et	 al.,	 2016;	 Ramírez‑












from	 membranous	 bone.	 Bones	 from	 varying	 skeletal	 regions	 contain	 different	
proportions	of	cortical	and	trabecular	bone.		
Cortical	 bone	 encloses	 the	 marrow	 space	 and	 is	 dense	 and	 solid.	 Trabecular	 bone	
comprises	of	a	honeycomb	like	grid	of	trabecular	plates	and	rods	scattered	in	the	bone	
marrow	compartment.	Cortical	and	trabecular	bone	are	both	made	up	of	osteons.		






A	 lamellar	 pattern	 is	 common	 for	 cortical	 and	 trabecular	 bone	 with	 collagen	 fibrils	
arranged	 in	 an	 alternating	 pattern.	 This	 alternating	 pattern	 gives	 lamellar	 bone	 its	
strength.	However,	 this	alternating	pattern	of	collagen	 fibrils	 is	not	present	 in	woven	
bone	which	makes	it	weaker	than	lamellar	bone	(Clarke,	2008).			
 Bone Growth, Modelling and Remodelling 
 
Bone	 can	 undergo	 different	 forms	 of	 physiological	 change	 throughout	 life,	 such	 as	
longitudinal	 and	 radial	 growth,	 modelling	 and	 remodelling.	 Longitudinal	 and	 radial	





by	 Wolff's	 Law	 (Chen	 et	 al.	 2010).	 Biomechanical	 forces	 can	 cause	 widening	 or	






This	 process	 involves	 constant	 elimination	 of	 distinct	 packets	 of	 old	 bone	 that	 are	
replaced	 with	 new	 matrix,	 and	 mineralisation	 of	 the	 matrix	 results	 in	 new	 bone	
formation.	Bone	remodelling	starts	before	birth	and	continues	until	death.		Remodelling	
is	a	tightly	coupled	process	involving	the	activity	of	osteoclasts	and	osteoblasts.		
The	 cycle	 of	 remodelling	 can	 be	 described	 as	 four	 consecutive	 phases	 that	 includes	
activation,	resorption,	reversal	and	formation.	The	sites	where	remodelling	takes	place	
normally	develop	randomly,	however,	sites	that	need	repair	maybe	be	targeted	(Burr,	
2002;	 Parfitt,	 2002).	 In	 the	 activation	 phase,	 mononuclear	 monocyte‑macrophage	
osteoclast	precursors	are	recruited	and	activated	from	the	circulation.	This	causes	the	
lining	cells	of	the	endosteum	to	detach	from	the	bone	surface	and	mononuclear	cells	to	




Each	 remodelling	 cycle	 that	 leads	 to	 bone	 resorption	 mediated	 by	 osteoclasts	 takes	
about	two	to	four	weeks.	Formation,	activation,	and	resorption	is	led	by	osteoclasts	and	
controlled	 by	 the	 proportions	 of	 receptor	 activator	 of	 nuclear	 factor	 kappa‑B	 ligand	
(RANKL)	to	osteoprotegerin	(OPG),	interleukin	1	(IL‑1)	and	interleukin	6	(IL‑6),	colony	
stimulating	factor	(CSF),	parathyroid	hormone,	1,25‑dihydroxyvitamin	D	and	calcitonin	
(Blair	 &	 Athanasou,	 2004;	 Boyle	 et	 al.,	 2003).	 Osteoclasts	 assist	 in	 mobilising	 bone	
mineral	by	releasing	hydrogen	ions	into	the	resorption	compartment	that	lowers	its	pH	
to	 approximately	 4.5.	 Resorbing	 osteoclasts	 also	 release	 tartrate‑resistant	 acid	
phosphatase,	cathepsin	K,	matrix	metalloproteinase	9,	and	gelatinase	from	cytoplasmic	
lysosomes	that	then	form	saucer‑shaped	Howship’s	lacunae	on	the	surface	of	trabecular	
bone	 and	 Haversian	 canals	 in	 cortical	 bone	 by	 breaking	 down	 the	 organic	 matrix.	











canaliculi	 and	 connected	 to	 each	 other	 by	 gap	 junctions	 (Burger	 et	 al.,	 2003).	 The	
osteocyte	network	forms	a	functional	syncytium	within	bone.	A	true	syncytium	results	
from	fusion	of	multiple	cells	to	a	single	multinucleated	cell;	the	osteocyte	network	has	a	






they	 act	 like	 a	 blood‑bone	 barrier	 and	 have	 the	 capacity	 to	 transform	 back	 into	
osteoblasts	 post‑exposure	 to	 parathyroid	 hormone	 or	 mechanical	 stimulation.	 Bone‑
lining	cells	in	the	endosteum	lift	off	the	bone	surface	prior	to	resorption	to	create	distinct	














demand	 for	 calcium	 and	 phosphorus	 increases.	 This	 demand	 can	 also	 be	 met	 by	
increased	activity	of	existing	osteoclasts	(Clarke,	2008).		
 Bone Cells: Osteoclasts, Osteoblasts, Osteocytes 
 










the	 Tumour	 Necrosis	 Factor	 (TNF)	 superfamily	 and	 is	 essential	 in	 the	 formation	 of	
osteoclasts.	M‑CSF	plays	a	role	in	proliferation,	survival	and	differentiation	of	osteoclast	
precursors.	M‑CSF	 is	 also	a	key	 factor	 for	survival	of	 osteoclasts	and	maintaining	 the	
cytoskeletal	rearrangement	needed	for	bone	resorption.		OPG	is	a	soluble	protein	and	
binds	with	RANKL	to	prevents	its	interaction	with	the	RANK	receptor	(Cohen,	2006).		
1.2.2.2 Osteoblasts  
 
Osteoblasts	arise	from	osteoprogenitor	cells	and	maintain	synthesis	of	new	bone	matrix.	
Osteocytes	 are	 entrapped	 within	 the	 bone	 matrix	 that	 supports	 bone	 structure.	




mesenchymal	 stem	 cell	 populations	 that	 possess	 the	 capacity	 to	 make	 new	 bone,	










When	 preosteoblasts	 stop	 multiplying,	 osteoblast	 precursors	 alter	 their	 shape	 from	
spindle‑shaped	 osteoprogenitors	 to	 large	 cuboidal	 differentiated	 osteoblasts	 on	 the	
surface	of	bone	matrix.	Preosteoblasts	that	are	present	near	functioning	osteoblasts,	in	
bone	remodelling	units,	are	identifiable	due	to	their	expression	of	alkaline	phosphatase	
(Clarke,	 2008).	 Mature	 osteoblasts	 that	 are	 active	 produce	 bone	 matrix,	 have	 large	
nuclei,	 enlarged	 Golgi	 bodies	 and	 broad	 endoplasmic	 reticulum.	 These	 osteoblasts	
release	type	I	collagen	and	other	matrix	proteins	vectorially	toward	the	bone	surface.		
Osteoblasts	 are	 diverse	 and	 possess	 the	 ability	 to	 express	 various	 repertoires.	 This	





Osteocytes	 terminally	 differentiate	 from	 osteoblasts	 and	 provide	 structural	 and	
metabolic	support	to	bone.	Osteocytes	are	found	within	the	lacunae	of	mineralised	bone	
and	possess	broad	filipodial	structures	that	are	present	in	the	canaliculi	of	mineralised	
bone.	 Typically,	 these	 cells	 do	 not	 express	 alkaline	 phosphatase,	 however,	 they	 do	
express	osteocalcin,	galectin	3	and	CD44,	a	cell	adhesion	receptor	for	hyaluronate,	and	
other	 matrix	 proteins	 that	 maintain	 intercellular	 adhesion	 and	 control	 exchange	 of	
mineral	 and	 fluid	 within	 the	 lacunae	 and	 canalicular	 network.	 During	 osteolysis,	
osteocytes	are	active	and	can	carry	out	phagocytosis	as	they	contain	lysosomes.			
Filipodial	cellular	processes	help	osteocytes	retain	associations	with	other	osteocytes	
and	 the	 bone	 surface.	 Maintenance	 of	 gap	 junctions	 between	 cells	 and	 direct	










inflows	 rapidly	 across	 filipodial	 gap	 junctions,	 information	 is	 transferred	 among	
osteoblasts	on	the	surface	of	the	bone	and	osteocytes	inside	the	bone.	Prostaglandin	E2,	
cyclo‑oxygenase	 2,	 various	 kinases,	 Runx2	 and	 nitrous	 oxide	 are	 involved	 in	 the	
signalling	mechanisms	associated	with	mechano‑transduction	process.		
Osteocytes	 can	 survive	 for	 decades	 in	 human	 bone	 without	 being	 involved	 in	 tissue	
turnover.	 Empty	 lacunae	present	 in	 old	bone	 indicate	 that	 osteocytes	can	go	through	
apoptosis,	and	this	is	usually	due	to	disturbance	in	their	intercellular	gap	junctions	or	
cell‑matrix	interactions	(Xing	&	Boyce,	2005).		










are	 derived	 exogenously,	 such	 as	 serum	albumin	 and	 α2‑HS‑glycoprotein	 and	 due	 to	
their	 acidic	 characteristics,	 they	 can	 bind	 to	 hydroxyapatite.	 Serum‑derived	
noncollagenous	 proteins	 can	 control	 matrix	 mineralisation	 and	 α2‑HS‑glycoproteins	





Osteoblasts	 that	 produce	 and	 release	 noncollagenous	 proteins	 can	 be	 classified	 into	






the	 surface	 of	 osteoblasts	 through	 a	 phosphoibositol	 link	 and	 is	 present	 freely	 in	
mineralised	matrix.	Alkaline	phosphatase	has	been	proposed	to	promote	extracellular	





 Bone Matrix Mineralisation 
 
The	composition	of	bone	includes	50	to	70%	mineral,	20	to	40%	organic	matrix,	5	 to	
10%	 water	 and	 less	 than	 3%	 lipids.	 The	 major	 mineral	 component	 of	 bone	 is	
hydroxyapatite	[Ca10(PO4)6(OH)2],	with	small	quantities	of	carbonate,	magnesium	and	
acid	phosphate	and	hydroxyl	groups	(Clarke,	2008).			
Expression	 of	 alkaline	 phosphatase	 and	 various	 noncollagenous	 proteins	 such	 as	
osteocalcin,	 osteopontin	 and	 bone	 sialoprotein	 have	 been	 associated	 with	 matrix	









bone	 margins	 of	 the	 socket.	 An	 imaginary	 line	 crosses	 the	 base	 of	 the	 socket	
perpendicularly	along	the	long	axis	of	the	root.	The	basal	bone	of	the	mandible	or	maxilla	
is	located	to	apical	this	line	(Araujo	et	al.,	2015).		










opposite	 side	 of	 the	 periodontal	 ligament,	 the	 Sharpey’s	 fibres	 are	 inserted	 into	 the	
cementum	 which	 attaches	 the	 periodontal	 ligaments	 to	 the	 dentin.	 Bundle	 bone	 is	
dependent	on	the	tooth	structure	and	is	relationship	to	the	cementum	and	periodontal	
ligament	on	the	tooth	roots	(Araujo	et	al.,	2015).	 




1.3.1.1 Dimensional Changes 
 
Multiple	human	studies	have	reported	changes	in	dimensions	in	the	alveolar	socket	post	
tooth	 extraction	 (Atwood,	 1963;	 Bergman	 &	 Carlsson,	 1985;	 Johnson,	 1963,	 1969;	
Pietrokovski	et	al.,	2007;	Schropp	et	al.,	2003;	Trombelli	et	al.,	2008).	Significant	vertical	
and	 horizontal	 contractions	 occur	 in	 the	 alveolar	 ridge	 following	 multiple	 tooth	
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extractions	 (Carlsson	 &	 Persson,	 1967;	 Johnson,	 1969).	 For	 individuals	 wearing	 full	
dentures	for	several	years,	the	resorption	in	the	alveolar	ridge	exhibit	wide	variations	
(Carlsson	et	al.,	1967).	Extraction	of	a	single	tooth	results	in	more	limited	dimensional	





















The	 inflammatory	 phase	 can	 be	 further	 divided	 into	 two	 sub‑phases:	 formation	 of	 a	
blood	 clot	 and	 migration	 of	 inflammatory	 cells.	 The	 tooth	 socket	 fills	 up	 with	 blood	
immediately	after	extraction	forming	a	platelet	plug.	In	the	next	2‑3	days	inflammatory	
cells	migrate	to	cleanse	 the	wound	prior	to	new	tissue	formation.	Inflammatory	cells,	














The	 third	 and	 last	 phase	 of	 socket‑healing	 is	 bone	 modelling	 and	 remodelling.	 Bone	
modelling	involves	alterations	in	the	shape	and	structure	of	bone.	Remodelling	involves	
changes	 without	 associated	 alterations	 in	 shape	 and	 structure.	 In	 the	 remodelling	












wall	 is	 thinner	 than	 the	 lingual	 wall,	 modelling	 causes	 more	 vertical	 bone	 loss.	 Bone	
modelling	 occurs	 earlier	 than	 bone	 remodelling,	 such	 that	 more	 than	 half	 of	 the	
modelling	 takes	 place	 within	 the	 first	 three	 months	of	healing	(Schropp	 et	 al.,	2003).	




1.4 Bone Healing  
 
Bone	 healing	 with	 grafting	 materials	 (bone	 or	 bone	 substitutes)	 can	 take	 place	 via	







into	 osteoblasts.	 The	 grafts	 are	 also	 a	 source	 of	 growth	 factors	 such	 as	 bone	















McLean,	 1952).	 Historically	 the	 most	 reliable	 way	 to	 determine	 the	 osteoinductive	
properties	of	a	material	was	to	inject	it	into	a	heterotopic	bed,	like	a	muscle	pouch,	and	
to	examine	 bone	 formation.	 Inductive	agents	naturally	 function	around	bone	as	 well;	






transforming	growth	 factor	 (TGF)‑β‑family	and	there	are	at	 least	 15	 identified	BMPs,	








Osteoconduction	 is	 a	 term	 used	 to	 describe	 bone	 growth	 on	 a	 surface.	 A	 surface	 is	
considered	osteoconductive	when	it	allows	bone	growth	on	its	surface	or	down	into	its	
pores	or	channels.	Osteoconduction	is	a	process	where	bone	is	absorbed	to	adapt	onto	
the	 surface	 of	 a	 material.	 However,	 this	 definition	 is	 restricted	 as	 it	 has	 little	 or	 no	
association	to	biomaterials	(Wilson‑Hench,	1987).		
In	 practice,	 osteoconduction	 is	 dependent	 on	 prior	 osteoinduction.	 Many	 different	
factors	 are	 essential	 for	 bone	 formation.	 Albrektsson	 (1980),	 examined	 in vivo	 bone	













 Osseointegration   
	
The	 term	 osseointegration	 was	 initially	 described	 by	 (Branemark	 et	 al.,	 1977)	 and	
(Albrektsson	 et	 al.,	 1981),	 who	 used	 light	 microscopy	 and	 described	 direct	 contact	
between	live	bone	and	implant.	From	a	biomechanical	perspective	it	has	been	described	
as	an	asymptomatic,	firm	fixture	of	alloplastic	materials	that	are	attained	and	retained	






1.5 Osteogenic Markers of Bone Healing  
 
For	 bone	 to	 adequately	 function,	 it	 is	 important	 to	 maintain	 a	 balance	 between	
osteoblasts	 and	 osteoclasts.	 Osteoblasts	 are	 activated	 and	 their	 differentiation	 is	
controlled	by	a	number	of	signalling	proteins	such	as	Wnt	signalling	pathways,	Indian	
Hedgehog	 and	 Runt‑related	 transcription	 factor	 2	 (Runx2).	 In	 addition	 to	 these	
signalling	 proteins,	 osteoblast	 differentiation	 and	 activation	 is	 also	 regulated	 by	
different	transcription	factors	and	genes	as	described	below.		
 Tumour Necrosis Factor Receptor Superfamily Member 11A (TNFRSF11A / RANK) 
 
Receptor	 activator	 of	 nuclear	 factor	 kappa	 B	 (RANK)	 is	 also	 known	 as	 TNF‑related	
activation‑induced	 cytokine	 (TRANCE)	 receptor	 or	 tissues	 necrosis	 factor	 receptor	
superfamily	 member	 11A	 (TNFRSF11A).	 RANK	 was	 first	 identified	 by	 Anderson	 and	
colleagues	(1997)	as	a	receptor	for	RANKL.	RANK	is	a	type	I	transmembrane	protein	and	
belong	to	the	tumour	necrosis	factor	receptor	(TNFR)	family.	RANK	is	made	up	of	616	
amino	 acids	 with	 four	 extracellular	 cysteine‑rich	 pseudo‑repeat	 domains	 (CRDs)	
(Anderson	et	al.,	1997).	Skeletal	muscle,	thymus,	 liver,	 large	intestine,	small	 intestine,	
adrenal	 glands,	 osteoclasts,	 epithelial	 cells	 in	 mammary	 glands,	 vascular	 cells	 and	
pancreas	all	express	RANK	(Sattler	et	al.,	2004).		




pathway,	 thus	 OPG	 acts	 a	 decoy	 receptor	 for	 RANK.	 Various	 signaling	 pathways	 are	
involved	in	the	differentiation	and	activation	of	osteoclasts	by	RANK.		
The	effects	of	RANK	on	osteoclasts	has	been	was	demonstrated	in	a	knockout	study	in	
mice.	 RANK	 deficient	 mice	 have	 shown	 to	 exhibit	 severe	 osteopetrosis	 attributed	 to	
inhibition	of	osteoclast	formation	(Dougall	et	al.,	1999).	This	observation	is	based	on	the	




osteoclast	 differentiation	 observed	 in	 RANK	 deficient	 mice	 is	 related	 to	 an	 inherent	
defect	in	the	hematopoietic	lineage.		
Tumour	 necrosis	 factor	receptor	 (TNFR)	 associated	 factor	 6	 (TRAF‑6)	 belongs	 to	 the	
tumour	necrosis	 factor	 (TNF).	Five	members	 of	 the	 TRAF	 family	 interact	with	 RANK,	
however,	and	TRAF‑6	has	been	an	essential	adaptor	molecule	for	RANK	and	regulator	
for	osteoclasts	formation	(Darnay	et	al.,	2007;	Lamothe	et	al.,	2007).			A	study	of	TRAF‑6	
deficient	 mice	 found	 that	 they	 exhibited	 osteopetrosis	 lesions,	 impaired	 bone	
remodelling	 and	 tooth	 eruption.	 The	 authors	 reported	 that	 these	 impairments	 were	
caused	by	diminished	osteoclast	function	(Lomaga	et	al.,	1999).	A	possible	mechanism	
for	this	is	that	TRAF‑6	can	transduce	RANK	signalling,	therefore	acting	as	a	regulator	for	
osteoclast	 activation	 (Darnay	 et	 al.,	 2007;	 Lomaga	 et	 al.,	 1999).	 In	 summary,	 these	
studies	provided	evidence	on	the	role	of	RANK	in	formation	and	activation	of	osteoclasts.	






and	 receptor	 activation	 of	 NF‑κB	 ligand	 (RANKL)	 (Theoleyre	 et	 al.,	 2004).	 Ikeda	 and	
colleagues	 (2001)	 described	 three	 isoforms	 of	 RANKL.	 The	 RANKL1	 and	 RANKL2	
isoforms	 have	 transmembrane	 domains	 with	 the	 ability	 to	 form	 complexes	 on	 cell	
membranes,	 made	of	multiple	 monomers	 (Ikeda	et	al.,	2001).	 RANKL3	 is	 soluble	and	
does	not	have	a	transmembrane	protein	domain.			
RANKL	is	a	glycoprotein	that	belongs	to	the	TNF	family.	RANKL	is	also	recognised	by	
other	 terminologies	 such	 as	 tumour	 necrosis	 factor	 ligand	 superfamily	 member	 11	
(TNFSF11),	TNF‑related	activation‑induced	cytokine	(TRANCE),	osteoprotegerin	ligand	
(OPGL)	and	osteoclast	differentiation	factor	(ODF).		Osteoblasts,	stromal	cells	and	T	cells	
can	 express	RANKL	 (Arabaci	 et	 al.,	 2015).	 RANKL	 expression	 can	 take	 place	 in	 three	
distinct	 molecular	 varieties	 and	 can	 consist	 of	 a	 trimeric	 transmembrane	 protein,	






RANKL	binds	with	a	homotrimeric	 disulfide‑linked	 form	of	RANK	onto	 the	 surface	of	
cells	 (Théoleyre	 et	 al.,	 2006).	 These	 interactions	 between	 RANK	 and	RANKL	 activate	
various	signaling	pathways	that	regulate	the	differentiation,	activation	and	survival	of	
osteoclasts	and	hence	regulate	resorption	of	bone	(Boyle	et	al.,	2003;	Lacey	et	al.,	1998).	
Kong	 and	 colleagues	 (1999)	 reported	 that	 RANKL‑deficient	 mice	 exhibited	 severe	
osteopetrosis	 and	 defective	 tooth	 eruption	 defects.	 This	 was	 attributed	 to	 the	
diminished	capability	of	osteoclasts	to	carry	out	osteoclastogenesis,	as	RANKL	deficient	
mice	demonstrated	a	total	absence	of	osteoclasts	(Kong	et	al.,	1999).		
 Tumour Necrosis Factor Receptor Superfamily Member 11B (TNFRSF11B/ OPG) 
 
The	 Amgen	 group	 was	 the	 first	 to	 discover	 osteoprotegerin	 (OPG)	 and	 found	 that	
increased	 expression	 of	 OPG	 was	 associated	 with	 osteopetrosis	 in	 transgenic	 mice	
(Simonet	 et	al.,	1997).	This	 study	demonstrated	 that	OPG	regulates	bone	density	and	
negatively	 regulates	 osteoclast	 maturation.	 Therefore,	 increased	 expression	 of	 OPG	
leads	to	increased	bone	mass	(osteopetrosis)	due	to	a	lack	of	osteoclasts	and	imbalances	
between	osteoblast	and	osteoclast	functions	(Simonet	et	al.,	1997).			








(Cys‑400)	 and	 this	 domain	 has	 a	 key	 role	 in	 dimerisation	 of	 OPG	 (Schneeweis	 et	 al.,	
2005).		
OPG	 is	 secreted	 by	 stromal	 cells	 and	 osteoblasts	 lineage	 cells.	 OPG	 acts	 as	 a	 decoy	











1998).	 In	 another	 study	 on	 OPG	 deficient	 mice,	 increased	 osteoclastogenesis	 was	




1.5.3.1 The RANK/ RANKL and OPG Axis 
 
The	RANK/	RANKL/	OPG	axis	has	multiple	physiological	roles	such	as	maintaining	bone	
homeostasis,	 immunity	 and	 osteoimmunology	 (Walsh	 &	 Choi,	 2014).	 The	 axis	 has	 an	
important	 role	 in	 pathologies	 such	 as	 inherited	 and	 acquired	 bone	 pathologies.	 This	
section	will	focus	on	the	role	of	the	RANK/	RANKL/	OPG	axis	on	bone	homeostasis	and	
bone	healing.		
The	 role	 of	 the	 RANK/	 RANKL/	 OPG	 axis	 plays	 in	 bone	 remodelling	 has	 been	 well	
established	with	transgenic	and	gene‑knockout	studies	(Wright	et	al.,	2009).	Osteocytes	





2011;	 Verborgt	 et	 al.,	 2000).	 The	 surrounding	 osteocytes	 respond	 to	 this	 signal	 and	
release	 growth	 factors	 and	 cytokines	 which	 stimulate	 bone	 marrow‑derived	
mesenchymal	stem	or	stromal	cells.	The	MSCs	in	turn	divide	and	differentiate	into	pre‑
osteoblasts.	 The	 pre‑osteoclasts	 are	 responsible	 for	 releasing	 Macrophage	 Colony‑
19 
 
Stimulating	 Factor	 (M‑CSF)	 and	 expressing	 RANKL	 (Sharaf‑Eldin	 et	 al.,	 2016).	 These	













remineralised	 by	 osteoblasts.	 The	 osteoblasts	 ultimately	 either	 undergo	 apoptosis	 or	
transform	into	osteocytes	(Kapasa	et	al.,	2017).	Overall,	a	higher	ratio	of	RANKL/	OPG	
























manner.	 In	 an	 alveolar	 healing	 model	 in	 rats,	 Hassumi	 and	 colleagues	 (2018)	
investigated	expression	of	RANKL	and	OPG	after	extraction	of	incisor	teeth	at	7,	14	and	
28	days.	The	IHC	results	 in	 the	study	showed	no	difference	in	the	expression	 level	of	
RANKL	 and	 OPG,	 as	 both	 showed	 moderate	 staining	 over	 the	 three	 healing	 points.	
RANKL	was	expressed	mostly	in	osteoblasts	and	fibroblasts	in	the	trabecular	bone	in	the	





















expressions	 of	 OPG	 and	 RANKL	 in	 the	 osteoporotic	 lesions	 treated	 with	 Biosilicate®.	




defects	 at	 six	 hours	 and	 one,	 four‑	 and	 six‑weeks	 post‑surgery.	 The	 study	 evaluated	
healing	and	RANK,	RANKL	and	OPG	using	IHC	at	three	time	point	over	six	weeks.	The	
study	showed	the	presence	of	OPG	only	in	unwounded	tissues.	RANK,	RANKL	and	OPG	





mostly	with	 the	connective	 tissues	and	its	expression	consistently	 increased	over	the	
healing	period	(Baharuddin	et	al.,	2015).	
The	randomised	controlled	 trial	conducted	by	Mandarino	et	al.	 investigated	with	one	
group	 with	 natural	 healing	 and	 the	 other	 group	 after	 receiving	 a	 dense	
polytetrafluoroethylene	 membrane.	 Over	 a	 healing	 period	 of	 four	 months,	 the	 mRNA	
expression	 for	 RANKL	 and	 OPG	 was	 similar	 in	 gingival	 fibroblasts	 and	 osteoblasts.	
Histological	assessments	showed	the	presence	of	osteoblasts	near	the	osteoid	tissues.	
Woven	 and	 mature	 bone	 were	 present	 in	 trabecular	 bone	 with	 an	 abundance	 of	
osteocytes	and	minimal	osteoblastic	activity	(Mandarino	et	al.,	2018).		
Expression	 of	RANK,	 RANKL	and	OPG	 has	also	been	evaluated	 in	natural	healing	and	










A	 histomorphometric	 and	 gene	 analysis	 study	 investigated	 natural	 healing	 against	













development	 (Davidson,	 1995).	 Hodgkinson	 and	 colleagues	 (1993)	 reported	 that	





Liu	 and	 colleagues	 (1999)	 used	 a	 mice	 calvarial	 model	 and	 found	 that	 an	 increased	
number	of	osteogenic	cell	when	Msx2	was	overexpressed.	The	overexpression	of	Msx2	
was	 associated	 with	 osteoblasts	 and	 resulted	 in	 the	 increased	 growth	 of	 the	 parietal	
bone	(Liu	et	al.,	1999).	Similar	findings	were	reported	in	a	chick	calvarial	model	(Dodig	
et	 al.,	 1999).	 Deficiencies	 of	 Msx2	 in	 mice	 have	 been	 reported	 to	 be	 associated	 with	








by	 Msx2	 (Ryoo	 et	 al.,	 1997;	 Towler	 et	 al.,	 1994).	 Msx2	 also	 has	 the	 ability	 to	 hinder	















al.,	 2008).	 Expression	 of	 osteoblastic	 genes	 such	 as	 osteocalcin	 (OCN),	 osteopontin	
(OPN),	collagen	type	I	(COL1)	and	bone	sialoprotein	BSP)	are	also	controlled	by	Sp7	(Sun	
et	al.,	2008).		



















In	 summary,	 it	 has	 been	 well	 documented	 in	 small	 animal	 models	 that	 Sp7	 plays	 an	
essential	 role	 in	 bone	 development.	 This	 is	 achieved	 by	 regulation	 of	 differentiation	
osteoblasts,	and	therefore,	Sp7	may	also	play	a	vital	role	in	bone	healing.		
 Collagen Type I alpha 1 chain (COL1A1) 
 
Type	 I	 collagen	 is	 the	 most	 common	 type	 of	 collagen	 in	 humans.	 Collagens	 provide	
strength	and	support	to	various	types	of	tissues	including	cartilage,	bone,	tendon,	skin	
and	sclera.	Type	I	collagen	consists	of	three	chains,	two	alpha‑1	chains	and	one	alpha‑




A	 mouse	 model	 was	 used	 to	 evaluate	 alveolar	 socket	 healing	 post	 extraction	 at	 zero	









authors	reported	that	 Col1A1	expression	 increased	 over	 the	 healing	periods	 for	both	





In	 summary,	 studies	 have	 demonstrated	 that	 Col1A1	 expression	 is	 a	 marker	 of	
extracellular	matrix	 production	essential	 for	adequate	bone	healing	especially	during	
the	early	phases	of	repair	and	regeneration.	 








ADAMs	 (A	 Disintegrin	 and	Metalloproteinases),	 such	 as	 tumour	 necrosis	 factor	alpha	
(TNF‑α)	 converting	 enzyme	 (Amour	 et	 al.,	 1998).	 This	 may	 explain	 how	 TIMP3	 can	




in	 mice	 reported	 that	 TIMP3	 deficient	 mice	 developed	 osteoarthritis	 at	 a	 faster	 rate	
compared	to	controls	(Clements	et	al.,	2003).	Various	studies	have	reported	that	 that	
TIMP3	 expression	 is	 greater	 in	 tissues	 that	 undergo	 massive	 remodelling	 especially	
during	embryonic	and	post‑natal	phases	and	in	tissues	with	high	turnover	rates	(Poulet	
et	 al.,	 2016).	 An	 ovine	 model	 evaluating	 mRNA	 expression	 of	 genes	 during	 hindered	
















wounds	 limited	 formation	 for	 new	 blood	 vessels	 after	 injury	 and	 during	 the	 healing	
process	(Biasutti	et	al.,	2017).		
A	 systematic	 review	 that	 evaluated	 the	 available	 evidence	 on	 the	 effects	 of	 gene	
expression	 in	 early	 healing	 of	 dental	 implants	 in	 humans,	 reported	 that	 TIMP3	 was	
identified	 to	 be	 involved	 in	 osteoclastic	 and	 remodelling	 activities	 (Shanbhag	 et	 al.,	
2015).	To	summarise,	evidence	suggests	that	TIMP3	plays	a	critical	role	in	regulating	
















These	 dimensional	 changes	 in	 the	 extraction	 socket	 can	 be	 minimised	 and	 bone	
deposition	 can	 be	 enhanced	 using	 bone	 grafts,	 bone	 substitute	 grafts	 or	 membranes,	
either	alone	or	in	combination.	This	procedure	is	known	as	alveolar	ridge	preservation.	
There	 are	 certain	 clinical	 scenarios	 where	 alveolar	 ridge	 preservation	 may	 not	 be	











 Inflammatory	 phase	 that	 is	 marked	 by	 recruitment	 of	 neutrophils,	 monocytes	
and	macrophages		






osteoblasts.	 This	 process	 is	 regulated	 by	 different	 growth	 and	 differentiation	
factors	leading	to	formation	of	woven	and	lamellar	bone	
 The	 last	 phase	 of	 remodelling	 is	 a	 continuous	 process.	 It	 is	 marked	 by	 bone	
coupling,	 where	bone	 resorption	 is	 carried	 out	by	osteoclasts	and	osteoblasts	
deposit	bone	throughout	life	(Giannobile	et	al.,	2019).		
The	 following	subsections	describe	the	 different	 bone	and	bone‑substitute	 grafts	and	
membranes	that	are	used	for	ridge	preservation.		




1.6.1.1 Autologous Grafts   
 
Autologous	bone	grafts	are	the	patient’s	own	bone	harvested	from	a	secondary	site(s)	
such	as	 the	ramus	or	mental	region	(chin)	of	the	mandible.	This	 type	of	bone	graft	 is	
considered	as	ideal	(de	Grado	et	al.,	2018;	Giannoudis	et	al.,	2011).	Autologous	grafts	are	
osteogenic,	as	 they	are	thought	 to	contain	the	patient’s	own	cells,	growth	factors	and	
biomolecules.	 They	 are	 also	 biologically	 safe,	 and	 biocompatible	 with	 corresponding	




1.6.1.2 Allografts  
 
Allografts	 are	 sourced	 from	 individuals	 (living	 or	 cadavers)	 of	 the	 same	 species	 but	







Allografts	 can	 be	 used	 as	 cortical	 wedges,	 chips	 or	 granules	 and	 cancellous	 bone	
powders.	 These	 grafts	 can	 be	 prepared	 as	 frozen,	 freeze‑dried,	 mineralised	 and	
demineralised	bone.	Examples	of	allografts	include	mineralised	bone	allograft	(Puros®),	
mineralised/	 demineralised	 bone	 allograft	 (Raptos®),	 demineralised	 bone	 matrix	










include	 risk	 of	 disease	 transmission,	 host	 immune	 reactions	 (Schroeder	 &	 Mosheiff,	
2011),	 and	decreased	osteoinductive	capacity	due	 to	 lack	of	viable	 cells	 attributed	 to	
manufacturing	 procedures	 (Zimmermann	 &	 Moghaddam,	 2011).	 The	 most	 common	
xenografts	used	in	dentistry	are	bovine	in	origin	with	no	reports	of	risk	of	Transmissible	
Spongiform	 Encephalopathies	 (TSE)	 and	 Bovine	 Spongiform	 Encephalopathy	 (BSE)	
(Kim	 et	 al.,	 2013).	 A	 retrospective	 study	 over	 20‑years,	 involving	 more	 than	 10,000	
implants	in	more	than	3,000	patients,	has	assessed	implant	therapy	with	and	without	
ridge	augmentation.	The	study	reported	that	deproteinised	bovine	bone	mineral	was	the	
most	 common	 bone	 graft	 used	 (>50%)	 and	 that	 DBBM	 grafts	 performed	 similarly	 to	
autologous	grafts	in	terms	of	implant	survival	in	a	private	practice	setting	(Knöfler	et	al.,	
2016).	In	a	systematic	review	of	40	randomised	controlled	trials	that	assessed	that	the	
effect	 of	 different	 grafting	 materials	 on	 ridge	 resorption (Majzoub	 et	 al.,	 2019),	 the	
authors	reported	that	similar	amounts	of	resorption	occurred	with	xenografts	(1.47	±	
0.92mm)	 and	 allografts	 (1.52	 ±	 1.29mm).	 Xenografts	 have	 slow	 resorption	 rates	 and	
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Some	 examples	 of	 xenografts	 include,	 anorganic	 porcine	 bone	 mineral	 (Gen‑Os®),	
deproteinised	 bovine	 bone	 mineral	 (Bio‑Oss®),	 anorganic	 bovine	 bone	 mineral	




Bio‑Oss®	 bone	 substitutes	 are	 made	 from	 the	 mineral	 component	 of	 bones	 from	
Australian	 cattle	 (bovine	 bone).	 The	 manufacturing	 process	 separates	 the	 organic	
components	 leaving	 the	hard	bony	parts	consisting	of	calcium	compounds.	 	The	hard	
inorganic	components	are	crushed	into	granules	and	treated	with	alkalis	and	chemicals	
under	temperatures	of	up	to	300⁰C	to	remove	any	remaining	organic	components.		
There	 are	 three	 main	 product	 formulations:	 Bio‑Oss®,	 Bio‑Oss	 Pen®	 and	 Bio‑Oss	
Collagen®.		Bio‑Oss®	and	Bio‑Oss	Pen®	are	both	available	as	small	granules	(0.25‑1	mm)	
and	 large	 granules	 (1‑2	 mm).	 Bio‑Oss	 Collagen®	 is	 composed	 of	 Bio‑Oss®	 granules	
together	with	10%	porcine	collagen	and	is	available	in	three	different	sizes:	0.2‑0.3	cm3,	
0.4‑0.5	cm3	and	0.9‑1.3	cm3.	
Bio‑Oss®	 is	 a	 commonly	 used	 xenograft	 for	 ridge	 preservation.	 Araujo	 and	 Lindhe	
(2009),	in	a	dog	study,	demonstrated	that	unfilled	sockets	underwent	three‑fold	more	





A	 9‑month	 observation	 of	 the	 effects	 of	 Bio‑Oss®	 on	 healing	 of	 extraction	 sockets	 in	
humans,	 demonstrated	 the	 osteoconductive	 properties	 through	 bony	 ingrowth	 and	
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osseointegration	 with	 newly	 formed	 bone	 (Artzi	 et	 al.,	 2001).	 Additionally,	 the	 study	
reported	the	presence	of	osteoblasts	inside	the	osteoid	layer	on	the	borders	of	the	newly	
formed	bone	and	graft	material.		
Overall,	 Bio‑Oss®	 is	 a	 widely	 used	 and	 well	 documented	 xenograft	 for	 ridge	
preservation	and	augmentation,	
1.6.1.4 Natural Biomaterials 
 
Natural	polymers	are	used	as	bone	grafting	materials	as	they	are	analogous	with	the	host	
extracellular	 matrix	 with	 regard	 to	 chemical	 make‑up	 and	 offer	 high	 osteoinduction	
(Haugen	 et	 al.,	 2019).	 Natural	 polymers	 can	 be	 classified	 into	 three	 types;	 proteins	
(collagen,	gelatine,	fibrinogen,	elastin);	polysaccharides	(glycosaminoglycans,	cellulose,	
amylose)	and	polynucleotides	(DNA,	RNA).		
These	 bone	 grafts	 possess	 high	 biocompatibility	 with	 reduced	 risk	 for	 host	
immunoreactivity.	Studies	have	demonstrated	that	natural	polymers	have	the	potential	
for	 differentiating	 mesenchymal	 stem	 cells	 into	 osteoblasts	 (Chung	 &	 Burdick,	 2009;	
Wang	 et	 al.,	 2005).	 There	 are	 additional	 concerns	 regarding	 the	 mechanical	
characteristics	of	the	newly	formed	bone	(Hannink	&	Arts,	2011;	Mano	et	al.,	2007).		





better	 than	 other	bone	 graft	 substitutes	 (Fuchs	 et	 al.,	 2001;	 Kretlow	 &	 Mikos,	 2007).	








 Dental Membranes  
 








1.6.2.1 Non-resorbable Membranes 
 




two	 main	 types	 of	 non‑resorbable	 barrier	 membranes,	 titanium	 and	
polytetrafluoroethylene	(PTFE).		
Titanium	 barrier	 membranes	 are	 physically	 strong,	 rigid	 and	 yet	 malleable.	 These	









Clinical,	 histological	 (Arbab	 et	 al.,	 2016)	 and	 biomolecular	 (Mandarino	 et	 al.,	 2018)	












Poly‑α‑hydroxy	 acids	 are	 the	 most	 common	 material	 for	 synthetic	 resorbable	
membranes.	 Some	 advantages	 of	 synthetic	 resorbable	 membranes	 are	 tuneable	
biodegradability,	 easy	 manageability	 and	 drug	 encapsulation	 (Sanz	 et	 al.,	 2019).			
However,	there	are	possibilities	of	immunological	reactions	that	can	cause	resorption	of	
regenerated	bone.	Resorption	rates	are	dependent	on	the	type	of	polymer	used.	Some	
examples	 of	 synthetic	 resorbable	 membranes	 include	 Epi‑Guide®,	 Resolut	 LT®,	
Artrisorb®,	Guidor®,	vicryl	periodontal	mesh®	and	Mempol®.		
Natural	 resorbable	 membranes	 are	 made	 up	 of	 human	 or	 animal	 collagen.	 They	 can	
either	 be	 non‑cross	 linked	 or	 cross‑linked.	 When	 non‑cross‑linked	 natural	 collagen	
membrane	 degrade	 they	 have	 not	 been	 shown	 to	 have	 adverse	 effects	 on	 tissues.	




inflammation	 associated	 with	 chemical	 remnants	 such	 as	 amides	 and	aldehydes.	 The	
origin	of	the	collagen	material	and	the	processing	protocols	such	as	decellularisation,	
sterilisation	 and	 cross‑linking	 methods,	 can	 all	 contribute	 to	 the	 predictability	 of	 the	
collagen	membranes	(Sanz	et	al.,	2019).		
Chitosans	 are	 polysaccharides	 that	 are	 made	 up	 of	 glucosamine	 and	 N‑
acetylglucosamine	(Kweon,	et	al.,	2003).	Chitosans	barrier	membranes	are	non‑woven	
and	 porous	 with	 good	 handling	 properties.	 These	 membranes	 have	 shown	 similar	
34 
 














1.7 Animal Models 
 
Animal	 models	 are	 a	 useful	 tool	 for	 assessing	 periodontal	 disease	 processes	 and	 to	
evaluate	 the	 effects	of	 various	 treatment	 modalities.	 Healing	of	periodontal	and	peri‑
implant	 tissues	 and	 regeneration	 after	 periodontal	 surgery	 using	 different	 biologic	
materials	can	be	studied	in	animals.	These	can	provide	useful	insights	for	possible	tissue	
engineering	strategies	involving	different	periodontal	tissue	compartments	such	as	the	
epithelium,	 connective	 tissues	 and	 alveolar	 bone	 (Bosshardt	 &	 Sculean,	 2009).	 The	
biology	 of	 periodontal	 and	 peri‑implant	 healing	 is	 complex	 hence	 animal	 models	 are	










housing	 facilities,	 dietary	 requirements	 and	 lighting.	 Appropriate	 care	 of	 animals	 by	
trained	personnel	before,	during	and	after	the	study	should	be	taken	into	consideration.	












Pearce	 and	 colleague	 (2007)	 consolidated	 the	 characteristics	 of	 bone	 from	 different	
animals	and	their	similarities	to	human	bone.			
Table 1:	Key	Attributes	in	Terms	of	Similarities	between	Animal	and	Human	Bone	
	 Rabbit Dog Pig Goat Sheep 
Macrostructure	 +	 ++	 ++	 +++	 +++	
Microstructure		 +	 ++	 ++	 +	 +	
Bone	Composition	 ++	 +++	 +++	 ++	 ++	
Bone	Remodelling		 +	 ++	 +++	 ++	 ++	
+	least	similar,	++	moderately	similar,	+++	most	similar		
Adapted	from	Pearce,	et	al.,	2007		
 Small Animals  
 
Despite	 having	 limited	 similarities	 to	 human	 bone	 and	 dentition,	 small	 animals	 have	









mouse	 calvaria	 model	 has	 been	 used	 in	 different	 periodontal	 research	 including	









allows	 various	 immunohistochemical	 end‑points	 to	 be	 studied	 in	 mice,	 including	
knockout	studies	against	different	genetic	backgrounds.	The	availability	of	the	mouse	
genome	 also	 allows	 the	 roles	 of	 genes	 in	 disease	 regulation,	 inflammation	 and	
regeneration	including	periodontal	disease	to	be	studied.		






implants	 (Abrahamsson,	 2011;	 Caiazza	 et	 al.,	 1991;	 Slotte	 et	 al.,	 2003).	 Some	 studies	
have	 reported	 that	 rabbit	 models	 are	 not	 adequate	 for	 periodontal	 ligament	
regeneration	(Oortgiesen	et	al.,	2010;	Tyrrell	et	al.,	2002).		
 Large Animals  
 
Large	 animals	 have	 similar	 dental	 anatomy	 to	 that	 of	 human,	 and	 this	 allows	 better	









use	 of	 dog	 models	 for	 guided	 tissue	 regeneration	 (GTR)	 studies	 dates	 to	 the	 1980s	
(Nyman	et	al.,	1980).	A	number	of	studies	have	shown	the	evaluation	of	bone	substitutes	
(Levy	et	al.,	1981;	Plotzke	et	al.,	1993;	Sugaya	et	al.,	1990;	Sugaya	et	al.,	1989)	and	the	













are	 able	 to	 tolerate	 certain	 environmental	 conditions	 like	 hot	 and	 humid	 conditions	
better	than	other	animals	like	sheep	(Leung	et	al.,	2001).	Studies	have	described	goats	




1.7.2.3 Miniature Pigs  
 




been	 studied	 using	 this	 model	 (Buser	 et	 al.,	 1998;	 Hamp	 et	 al.,	 1972;	 Naaman	 Bou‑
Abboud	 et	 al.,	 1994;	 Schliephake	 &	 Aleyt,	 1998),	 and	 the	 healing	 process	 has	 been	
reported	similar	to	humans	(Buser	et	al.,	1998).		
1.7.2.4 Nonhuman Primates  
 
Nonhuman	 primates	 have	 oral	 structures	 that	 are	 similar	 to	 that	 of	 the	 human,	 with	
similar	 permanent	 dentition,	 however,	 the	 size	 of	 the	 teeth	 are	 smaller.	 The	
dentogingival	and	periodontal	fibres	have	similar	organisation	to	humans.	These	models	
have	been	described	as	suitable	for	periodontal	regenerative	procedures	(Caton	et	al.,	
1994;	 Schou	 et	 al.,	 1993).	 Min	 and	 colleagues	 (2016)	 used	 a	 monkey	 model	 for	 an	
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alveolar	 ridge	 preservation	 study	 and	 reported	 similar	 findings	 to	 human	 and	 dog	
studies	 (Min	 et	 al.,	 2016).	 Similar	 studies	 have	 been	 carried	 on	 monkeys	 to	 assess	
periodontal	healing	using	biomaterials	(Drury	&	Yukna,	1991;	Karatzas	et	al.,	1999;	Su	
et	al.,	2017),	and	guided	tissue	regeneration	(Kostopoulos	&	Karring,	2004).	
Even	 though	 nonhuman	 primates	 provide	 a	 satisfactory	 model	 for	 studying	 different	
aspects	 of	 periodontal	 diseases	 and	 treatment	 modalities	 this	 model	has	 some	 major	
drawbacks.	It	is	expensive	to	buy	and	maintain	monkeys	and	at	the	same	time	they	can	
be	violent	and	can	carry	diseases,	especially	those	that	are	captured	wild	(Schou	et	al.,	
1993).	 Monkeys	 are	 also	 susceptible	 to	 systemic	 infections	 and	 diseases	 which	 make	
post‑operative	healing	and	care	difficult	(Weinberg	&	Bral,	1999).		









with	 about	 two	 central	 blood	 vessels	 and	 no	 cement	 line	 (deKleer,	 2006).	 This	 is	
different	 from	 human	 bones	 that	 mostly	 contain	 secondary	 bone	 (Eitel	 et	 al.,	 1981).	
Sheep	bone	has	also	been	reported	to	be	denser	than	that	of	humans	(Nafei	et	al.,	2000).	































































2.1 Ethical Considerations 
 
All	aspects	of	the	study	were	approved	by	the	Otago	University	Animal	Ethics	Committee	







2.2 Surgical Materials and Equipment 
 








 Bio-Gide®   
 











 Implant Bur  
 





 Trephine  
 
Tissue	 samples	 for	 RNA	 analysis	 were	 recovered	 using	 a	 2	 mm	 diameter	 trephine	
(Meisigner,	Neuss,	Germany)	from	the	third	premolar	on	the	right	side	of	the	mandible.		
		











were	 excluded	 from	 the	 study.	 To	 reduce	 outbred	 heterogeneity,	 all	 animals	 were	
selected	from	one	farm	and	at	random	from	a	larger	pool	at	the	farm	site	(AgResearch,	
Invermay).	



























































































































































2.5 Surgical Protocol 
 
2.5.1 Pre-Surgical Work-up  
 
The	 sheep	 were	 treated	 with	 anthelmintic	 and	 clostridia	 vaccines,	 prior	 to	
transportation	 to	 the	 research	 facility.	 For	 acclimatisation,	 the	 sheep	 were	 kept	 in	
approved	indoor	housing	at	the	research	facility	for	a	minimum	of	seven	days	prior	to	
surgery	and	provided	with	hay,	pellets	and	water.	Food	was	withheld	12	hours	before	
surgery.	 Surgery	 was	 performed	 under	 standard	 sterile	 operating	 techniques	 at	
Invermay	Agricultural	Research	Centre,	Mosgiel.		
All	 sheep	 received	 a	 subcutaneous	 dose	 of	 the	 antibiotic	 Trimethoprim	 (Amphoprim	
injection	 1	 mL/15	 kg,	 Virbac	 New	 Zealand	 Ltd.,	 Auckland,	 New	 Zealand)	 1	 hr	 before	
surgery.		
	











 Disinfecting Surgical Site 
 
The	face	was	trimmed	of	wool	and	prepared	with	Betadine.	The	oral	cavity	was	prepared	





 Local Anaesthesia  
 
A	 local	 dental	 anaesthetic	 infiltration	 (Lignospan®	 Lignocaine	 Hydrochloride	 B.P.	 2%	
with	 Adrenaline	 1:80,000)	 was	 administered	 adjacent	 to	 the	 operative	 sites	 for	 the	
purpose	of	decreasing	immediate	post‑operative	discomfort	and	providing	a	degree	of	
haemostasis	 during	 the	 surgery.	 Additional	 local	 anaesthesia	 was	 also	 administered	
following	the	completion	of	the	surgical	procedure.		
	
 Tooth Extraction Protocol  
 




of	 dental	 elevators	 gently	 tapped	 with	 a	 surgical	 mallet.	 Molar	 extraction	 forceps	
together	with	Coupland’s	and	Cryer’s	elevators	and	luxators	were	used	to	mesially	luxate	







 Preparation of Grafting Site 
 
As	 the	 size	 of	 each	 socket	 is	 different	 and	 also	 varies	 across	 individual	 animals,	 the	
sockets	 were	 standardised	 using	 implant	 burs	 to	 at	 least	 11	 millimetres	 deep	 x	 5.2	






 Grafting of Extraction Sites  
 
Bio‑Oss®	was	introduced	in	the	prepared	socket	using	a	2cc	syringe	that	was	modified	





















 Post-Surgery Care and Recovery  
 
Post‑surgery,	animals	were	housed	in	sheep	pens	for	five	to	seven	days	and	given	food	
(small	 pellets	 or	 muesli‑type	 feed)	 and	 water	 twice	 daily.	 The	 anti‑inflammatory	





applied	 daily	 to	 the	 intraoral	 surgical	 sites	 via	 a	 20	 mL	 syringe.	 The	 veterinary	 staff	
monitored	and	documented	any	anomalies	for	a	minimum	of	three	days	post‑surgery.	
Monitoring	 included	 food	 and	 water	 intake,	 behaviour	 and	 any	 complications	 to	 the	
defect	site	or	animal	health.	Health	and	behaviour	were	assessed	by	observing	animals’	
mannerism	 including,	 but	 not	 limited	 to,	 gait	 and	 movement,	 posture,	 respiration,	
vocalisation	and	 faecal	consistency.	 Defect	complications	were	assessed	 by	observing	
site	haemorrhage,	oedema	and	infection.	Central	nervous	system	(CNS)	complications,	
indicating	an	anaesthetic	complication	immediately	after	surgery,	or	other	behavioural	
indicators,	 such	 as	 self‑mutilation	 were	 closely	 monitored	 in	 the	 first	 48	 hours	 after	
surgery	and	with	any	complications	noted.		
 Post-Operative Recovery to Euthanasia 
 
Following	post‑operative	recovery,	up	until	euthanasia,	the	animals	were	housed	in	farm	





Following	 healing	 periods	 of	 4‑,	 8‑	 and	 16‑weeks,	 10	 animals	 per	 time	 point	 were	
euthanized.	General	anaesthesia	was	induced	with	an	intravenous	infusion	of	Diazepam	
(0.2	 mg/kg)	 and	 Ketamine	 (2	 mg/kg,	 intubated	 orally	 and	 general	 anaesthesia	 was	
maintained	using	isoflurane	2.5	to	3.5%	to	effect.		
	










catheters	 (Optiva™,	 Smiths	 Medical,	 UK).	 The	 catheters	 were	 ligated	 firmly,	 while	
maintaining	patency,	to	prevent	dislodging	the	cannula.		
	




perfused	 bilaterally	 to	 fix	 the	 tissues.	 Following	 the	 anaesthetic	 overdose,	
exsanguination	 and	 fixation	 the	 euthanasia	 time	 was	 recorded	 and	 the	 surgical	 sites	
were	identified.  
 









2.6 Specimen Preparation for Immunohistochemistry 












The	 decalcification	 process	 used	 in	 this	 study	 was	 described	 by	 Baharuddin	 and	






An	 oxalate	 test	 was	 employed	 to	 confirm	 decalcification.	 A	 sample	 of	 the	 EDTA	
decalcification	 buffer	 (5	 mL)	 was	 taken	 from	 the	 pottle	 containing	 the	 bone	 and	
concentrated	hydrochloric	acid	(HCl)	(Merck®,	Germany)	added	to	the	solution	until	a	
pH	3.2	‑	3.6	was	achieved.	Litmus	paper	was	used	to	determine	the	pH	of	the	solution.	A	
solution	 of	 3%	 di‑ammonium	 oxalate	 monohydrate	 (5	 mL;	 Extra	 pure;	 Merck®,	
Germany)	was	then	added	and	left	to	incubate	at	RT	for	30	mins.	A	cloudy	appearance	
indicated	 incomplete	 decalcification	 (see	 Appendix	 II	 for	 buffer	 recipe).	 The	 samples	













 Paraffin Embedding 
 
The	 embedding	 process	 was	 carried	 out	 using	 an	 automatic	 processing	 machine	
(Excelsior™	 ES	 tissue	 processor,	 Thermo	 Scientific™,	 Waltham,	 USA).	 The	 specimens	
were	prepared	using	Routine	Overnight	program	cycles	with	a	series	of	formalin,	graded	
ethanol,	 xylene,	 and	 paraplast	 wax	 (56°C	 melting	 point)	 steps.	 See	 appendix	 III	 for	
protocol.	Following	processing,	the	tissue	was	embedded	in	molten	paraffin	(62°C)	in	an	








the	 sections	 onto	 SuperFrost	 Ultra	 Plus™	 Adhesion	 Slides	 (J3800AMNZ,	 Thermo	
Scientific™).	 A	 number	 of	 slide	 adhesion	 chemistries	 were	 tested	 to	 ensure	 optimal	
tissue	adherence	(Appendix	III).	The	slides	were	labelled	and	incubated	for	20	min	at	
45°C	 to	 dry	 the	 slides	 and	 then	 placed	 at	 60°C	 overnight.	 The	 prepared	 slides	 were	
placed	in	an	air‑tight	container	and	stored	at	4°C	until	required.		
	




















2.7 Immunohistochemistry  
 
RANKL,	RANK	and	OPG	protein	detection	was	carried	out	using	immunohistochemistry.	
Due	 to	 the	 unavailability	 of	 sheep	 antibodies,	 human	 or	 rat	 antibodies	 were	 used.	
Antibodies	 were	 selected	 based	 on	 the	 sheep	 protein	 sequence	 homology	 with	 the	
human	or	rat	sequence.	Protein	sequences	were	retrieved	from	the	National	Center	for	
Biotechnology	 Information	 (NCBI)	 and	 aligned	 using	 BLAST®	 software	
(www.ncbi.nlm.nih.gov).	It	was	necessary	to	optimize	antigen	retrieval	methods	for	each	
of	the	antibodies.		




provided	 the	 best	 adherence	 of	 decalcified	 sheep	 alveolar	 socket	 tissues	 during	
immunohistochemistry.	 The	 following	 variables	 were	 tested	 (full	 protocol	 is	 given	 in	
Appendix	III):		
i. Different	 types	 of	 slides:	 Uber	 slides,	 Adhesive	 Trajan	 (806052N‑SP3A,	 Trajan	
Scientific	and	Medical);	Crest	Adhesive	(803158R‑SP3A,	Matsunami	Glass	Ltd);	
and	Superfrost	Ultra	Plus®	(J3800AMNZ,	Thermo	Scientific).		
ii. Incubation	 of	 slides	 post	 paraffin	 embedding	 (incubated	 at	 60⁰C	 overnight	 or	
incubated	at	RT).	




















The	 OPG	 antibody	 concentrations	 was	 trialled	 at	 2.5	 µg/mL	 (dilution	 1:400)	 and	 5	
µg/mL	 (dilution	 1:200).	 The	 negative	 controls	 were	 also	 tested	 at	 the	 same	
concentrations,	mouse	IgG	2.5	µg/mL	(dilution	1:160)	and	5	µg/mL	(dilution	1:80).		
 Primary antibody Selection 
 
2.7.2.1 RANKL Antibody 
 




2.7.2.2 RANK Antibody  
 




2.7.2.3 OPG Antibody  
 
A	 monoclonal	 mouse	 anti‑human	 OPG	 antibody	 (NB100‑56505,	 Novusbio)	 was	 used.	





 Secondary Antibody Selection   
 
The	secondary	antibody	for	both	RANKL	and	RANK	was	a	polyclonal	biotinylated	goat	




The	 secondary	 antibody	 for	 OPG	 was	 a	 biotinylated	 polyclonal	 rabbit	 anti‑mouse	
(ab5761,	 Abcam),	 conjugated	 with	 Biotinamidocaproate	 N‑Hydroxysuccinimide	 Ester	
(BAC)	Biotin/Protein	Ratio:	10‑20	BAC	molecules	per	Rabbit	IgG	F(ab')2	molecule.		The	
secondary	antibody	was	used	as	1:500	dilution	using	1%	BSA/	5%	rabbit	serum/	PBS.		
 Antigen Retrieval Methods 
 
2.7.4.1 Heat Retrieval for RANKL and RANK 
 
A	number	of	temperatures	and	durations	were	tested.	A	final	antigen	retrieval	protocol	
using	 0.1M	 tri‑sodium	 citrate	 (pH	 6.0)	 at	 80°C	 for	 15	 mins	 in	 a	 Decloaking	 chamber	
(NxGen,	Biocare	Medical)	was	used.			
















 Immunohistochemistry (IHC) Protocols 
 
Full	protocols	 for	 the	 immunochemistry	procedures	 are	given	 in	 Appendix	 II.	 All	 IHC	
procedures	 were	 carried	 out	 on	 the	 bench	 at	 room	 temperature	 (20	 to	 25°C)	 unless	
otherwise	stated.		
Prior	 to	 the	 procedure,	 all	 slides	 were	 clearly	 labeled.	 The	 slides	 were	 de‑waxed	 in	

































 Slide Scoring  
	
The	region	of	interest	(ROI)	was	scored	according	to	the	strength	of	staining	associated	







2.8 RNA Expression Analysis  
	




16	 weeks	 at	 the	 osteotomy	 site	 (within	 the	 gap	 and	 along	 the	 periosteal/endosteal	
surfaces	of	the	bone	fragments).	Tissue	was	collected	from	seven	test	sites	(BioOss®	+	
Biogide®)	and	seven	control	sites	(no	graft	+	no	membrane)	at	each	time	point,	with	a	
total	 of	 21	 samples	 collected	 (see	 Appendix	 I).	 The	 tissue	 was	 placed	 in	 RNAlater™	
storage	solution	(AM7020,	Invitrogen,	Thermofisher	Scientific)	and	stored	at	‑80°C	until	
required.	
 Tissue Homogenisation  
 
All	 instruments	 used	 for	 RNA	 extraction	 procedures	 were	 rinsed	 well	 with	 RNase	
AWAY™	 reagent	 (10328‑011,	 Ambion,	 Life	 Technologies)	 to	 remove	 RNases.	 Using	




pause	 between	each	cycle	were	used.	 A	constant	 temperature	of	 4°C	 was	 maintained	
throughout	 the	 grinding	 process.	 The	 homogenate	 was	 recovered	 from	 the	 lysing	 kit	
tube	with	TRIzol®	(500	µL,	15596026,	Ambion	Life	Technologies),	and	stored	at	‑80°C	
until	required.			
 RNA Extraction  
 
RNA	was	extracted	from	the	homogenates	using	a	PureLink™	RNA	Mini	Kit	(1939052,	









same	 collection	 tube.	 Wash	 Buffer	 I	 (700	 µL)	 was	 added	 to	 the	 spin	 cartridge	 and	











 RNA Concentration  
 
The	 GeneJET	 RNA	 Cleanup	 and	 Concentration	 Micro	 Kit	 (Thermo	 Scientific,	 K0841,	
K0842)	 was	 used	 to	 concentrate	 RNA	 samples	 which	 were	 <	 300	 ng/µL	 in	 order	 to	
achieve	the	correct	concentration	for	the	next	cDNA	synthesis	step.		
Nuclease‑free	water	(150	µL)	was	added	to	the	RNA	sample	followed	by	Binding	Buffer	
(100	 µL)	 and	 ethanol	 (300	 µL;	 96‑100%)	 and	 mixed	 well	 after	 each	 addition.	 The	
solution	 was	 then	 transferred	 to	 the	 purification	 column	 with	 collection	 tube	 and	
centrifuged	 for	 60	 secs	 a	 14000	 g	 at	 RT.	 The	 flow‑through	 was	 discarded	 and	 the	










RNA.	 The	 concentrations	 of	 RNA	 in	 the	 homogenate	 were	 determined	 using	 the	
NanoPhotometer™	(Implen	NanoPhotometer®).	The	purification	column	was	discarded,	
and	 the	 purified	 RNA	 was	 stored	 at	 ‑20°C	 until	 required.	 An	 absorbance	 ratio	
(A260:A280)	 of	 >1.8	 was	 considered	 optimum	 quality	 RNA	 for	 qPCR	 analysis	 as	 it	
signifies	that	the	RNA	is	pure.	
	
















 Primer Selection and Design  
 
A	number	of	ovine	reference	genes	were	tested	for	their	suitability	for	the	normalisation	

















































































 mRNA expression analysis  
 
SYBR	 green	 quantitative	 reverse	 transcriptase	 polymerase	 chain	 reaction	 (qRT‑PCR)	
assays	were	employed	to	determine	the	mRNA	expression	levels.	A	master	mix	for	25	
samples	 was	 prepared	 for	 each	 of	 the	 seven	 genes	 of	 interest	 (GOI)	 and	 a	 selected	
reference	gene.	A	master	mix	was	prepared	using	SYBR	Green	(25	µL;	4385612,	Thermo	










 Data Analysis for Real-time Quantitative Reverse Transcriptase-Polymerase Chain 
Reaction Analysis (qRT-PCR) 
 
The	reference	gene	with	the	most	consistent	Cq	and	melting	points	was	selected	for	this	
study.	 	 Data	 analysis	 was	 performed	 using	 GraphPad	 Prism	 software	 V7	 (GraphPad	
Software	Inc.,	San	Diego,	USA).	Changes	in	gene	expressions	were	assessed	as	described	
Lienau	and	colleagues	(2010).	Cq	and	melting	point	data	were	used.	The	Cq	value	reflects	
the	 gene	 expression	 level,	 the	 higher	 the	 Cq	 value	 the	 lower	 the	 gene	 expression.	 Cq	














Chapter 3 Results 
 







3.2  Immunohistochemistry 
 
3.2.1  Decalcification and Paraffin Embedding 
  
The	alveolar	sockets	were	decalcified	in	EDTA	pH	of	7.4.	As	the	sockets	were	collected	




Table 4: Tissue	Decalcification	Time 
	 Healing Time Points (Weeks) 
4 8 16 
Time	taken	for	decalcification	(days)	 112‑	135	 139‑287	 139‑287	
Number	of	blocks	embedded	in	paraffin	 45	 43	 41	











address	 this,	 slides	 with	 different	 adherence	 chemistries	 were	 investigated,	 as	 were	
different	 antigen	 heat	 retrieval	 temperatures	 and	 times	 (Appendix	 III).	 The	 greatest	
tissue	adherence	was	achieved	using	Superfrost	Ultra	Plus®	(Thermo	Scientific,	Cat	#:	
J3800AMNZ)	 slides.	The	 optimum	heat	 antigen	retrieval	was	 achieved	 at	 80°C	 for	15	
minutes.		
3.2.3  Optimal Antibody Concentrations  
 
All	 IHC	 procedures	 were	 carried	 out	 on	 the	 bench.	 Optimal	 primary	 antibody	
concentrations	are	described	in	Table	5.		
Table 5: Optimum	Antibody	Concentrations 






3.2.4  Histological Assessment of Masson's Trichrome Staining 
  
Trichrome	 staining	 was	 carried	 out	 on	 a	 total	 of	 eighteen	 sections,	 three	






3.2.4.1 Histological Assessment at 4-Weeks 
 
By	 4‑weeks,	 soft	 tissue	 healing	 was	 present	 in	 both	 the	 control	 and	 test	 samples	 as	
evident	by	epithelium	and	connective	tissue	forming	over	the	socket	opening	and	the	
socket	 were	 surrounded	 by	 lamella	 bone.	 Unlike	 the	 control	 group	 (Figure	 8	 A&C)	 a	
bridge	of	woven	bone	can	be	seen	over	the	socket	opening	in	the	test	group	(Figure	8	
B&D).	 Woven	 bone	 however,	 was	 present	 on	 the	 lateral	 edges	 of	 the	 socket	 in	 both	
groups.		Minimal	to	no	Bio‑Oss®	particles	were	observed	in	the	test	samples.		
	







3.2.4.2 Histological Assessment at 8-Weeks 
  
In	 the	 8‑week	 time	 point	 control	 and	 test	 samples,	 complete	 soft	 tissue	 healing	 was	







Figure 9: Masson's Trichrome staining of 8-Week samples.  





3.2.4.3 Histological Assessment at 16-Weeks 
  
Compared	 to	 4‑	 and	 8‑week	 samples,	 there	 was	 complete	 soft	 tissue	 healing	 in	 both	
control	and	test	samples	as	evident	by	closure	of	the	socket	opening	with	epithelium	and	
underlying	dense	connective	tissues.	In	both	groups	there	was	presence	of	woven	bone	








Figure 10: Masson's Trichrome staining for 16-Week samples.  























Cell or Tissue 
Type 
RANKL RANK OPG 
Control Test Control Test Control Test 
4	
Osteoclasts	 +++	 +++	 +++	 ++	 ++	 ++	
Osteoblasts	 +++	 +++	 ++	 ++	 ++	 ++	
Connective	tissue	 +	 +	 +	 +	 +++	 +	
	 Control Test Control Test Control Test 
8	
Osteoclasts	 +++	 +++	 ++	 +++	 +++	 +++	
Osteoblasts	 +++	 +++	 ++	 ++	 ++	 ++	
Connective	tissue		 +	 +	 +	 +	 +++	 +++	
	 Control Test Control Test Control Test 
16	
Osteoclasts	 +++	 +++	 +++	 +++	 +++	 +++	
Osteoblasts		 +++	 +++	 +	 +	 +	 +	
Connective	tissue		 +	 +	 +	 +	 +	 +	
74 
 




osteoblasts	 was	 found	 around	 new	 bone.	 At	 8	 and	 16	 weeks,	 staining	 of	 RANKL	 on	
osteoclasts	 was	 more	 apparent	 around	 remodelling	 bone	 on	 the	 edges	 of	 the	 socket.	
Localisation	of	RANKL	in	the	connective	tissues	appeared	to	be	isolated	and	mild	across	
both	groups	and	all	time	points	(Figure	11	A–F).	No	positive	staining	was	observed	in	
the	negative	controls	 for	RANKL	 (Figure	 11	 G&H).  	Minimal	 to	 no	Bio‑Oss®	 particles	
were	observed	in	the	test	samples.		
	
Figure 11: Immunohistochemical localisation of RANKL and Rabbit IgG (negative control) at 
coronal edge of the dental alveolus.  
Strong	 immunopositive	 staining	 for	 RANKL	 (brown	 colouration)	 was	 observed	 on	 osteoblasts	 and	
osteoclasts	both	 in	the	control	and	test	groups.	Bio‑Oss®	was	not	observed	in	the	 test	samples.	(A)	 4‑
weeks	control	(B)	4‑weeks	test	(C)	8‑weeks	control	(D)	8‑weeks	test	(E)	16‑weeks	control	(F)	16‑weeks	
















Figure 12: Immunohistochemical localisation of RANK and Rabbit IgG (negative control) at 
coronal edge of the dental alveolus.  
Moderate	 immunopositive	 staining	 for	 RANK	 (brown	 colouration)	 was	 observed	 on	 osteoblasts	 and	






3.2.5.3 IHC Assessment for OPG 
  
Localisation	of	OPG	in	the	connective	tissues	appeared	diffuse	and	was	stronger	during	
the	 early	 healing	 periods	 and	 gradually	 decreased	 over	 time.	 At	 4	 weeks	 moderate	
staining	of	OPG	was	observed	on	osteoblasts	and	osteoclasts	both	in	the	control	and	test	
groups	(Figure	13	A–B).	OPG	staining	on	osteoblasts	was	moderate	at	8	weeks	and	mild	
at	 16	 weeks	 in	 both	 groups.	 However,	 strong	 staining	 of	 OPG	 was	 associated	 with	
osteoclasts	in	both	the	control	and	test	groups	at	8	and	16	weeks	of	healing	(Figure	13	
C–F).	 No	 positive	 staining	 was	 observed	 in	 the	 negative	 controls	 for	 OPG	 (Figure	 13	
G&H).	Minimal	to	no	Bio‑Oss®	particles	were	observed	in	the	test	samples.		
	
Figure 13:	Immunohistochemical localisation of OPG and Mouse IgG (negative control) at coronal 
edge of the dental alveolus	
Strong	immunopositive	staining	for	OPG	(brown	colouration)	was	observed	on	connective	tissue	both	in	
the	control	and	test	groups.	Bio‑Oss®	was	not	observed	in	the	test	samples.	(A)	4‑weeks	control.	(B)	4‑





3.3 Gene Expression Analysis  
	
Gene	expression	analysis	was	carried	out	at	three	time	points,	4,	8	and	16	weeks.	Third	







fine	 power	 it	 produced	 could	 not	 be	 recovered	 effectively.	 To	 overcome	 this,	 an	
automated	homogeniser	(Precellys®	Evolution,	Bertin	Technologies,	France)	designed	
for	smaller	samples	was	used	to	homogenise	the	tissue.		
































Total RNA  
1	 597‡	 4	 C	 0.045	 1.704	 18.4	 920	
2	 432	 4	 B	 0.198	 1.756	 60.4	 3020	
3	 586*	 4	 C	 0.320	 1.899	 128.0	 6400	
4	 441	 4	 B	 0.149	 1.886	 59.6	 2980	
5	 583‡	 4	 C	 0.028	 1.556	 11.2	 560	
6	 428	 4	 B	 0.091	 1.820	 36.4	 1820	
7	 595	 4	 C	 0.081	 1.745	 32.8	 1640	
8	 440‡	 8	 C	 0.047	 1.750	 19.6	 980	
9	 589	 8	 B	 0.085	 1.771	 34.0	 1700	
10	 434†	 8	 C	 0.031	 1.833	 13.2	 660	
11	 598‡	 8	 B	 0.035	 1.667	 14.0	 700	
12	 426*	 8	 C	 0.152	 1.831	 60.8	 3040	
13	 438	 8	 B	 0.158	 1.847	 62.8	 3140	
14	 450	 8		 C	 0.169	 1.888	 67.2	 3360	
15	 430	 16		 C	 0.324	 1.878	 129.0	 6450	
16	 599	 16		 B	 0.096	 1.846	 38.4	 1920	
17	 584*	 16		 C	 0.119	 1.872	 47.2	 2360	
18	 585‡	 16		 B	 0.061	 1.848	 24.4	 1220	
19	 442†	 16	 C	 0.053	 1.828	 21.2	 1060	
20	 427‡	 16		 B	 0.048	 1.778	 19.2	 960	
21	 425	 16		 C	 0.095	 1.843	 37.6	 1880	
†	Samples	not	included	due	to	them	being	lost	in	the	cryo‑grinder	homogenising	procedure	*	Samples	used	
to	 validate	 reference	 gene	 ‡	 RNA	 samples	 which	 required	 concentration	 (<25ng/µL).	 As	 noted	 in	 the	











present	 in	 the	 cDNA	 template	 used	 for	 the	 SYBR	 Green	 assay)	 (Figure	 14A).	 Melting	
temperature	 values	 were	 also	 consistent,	 indicating	 a	 similar	 sized	 product	 was	
amplified	 for	each	RT+	cDNA	template	and	RT‑	samples	were	 indictive	of	no	product	
being	amplified	of	a	correct	size	(Figure	14B).		
For	 the	 ACTB	 primer	 set,	 high	 and	 consistent	 Cq	 values	 for	 the	 RT+	 samples	 were	
observed.	 The	 RT‑	 samples	 showed	 no	 detectable	 product	 amplification	 indicating	




The	 GAPDH,	 RPL19	 and	 YWHAZ	 primer	 sets	 failed	 to	 amplify	 the	 correct	 product	 as	
evident	by	inconsistent	Cq	values	for	the	RT+	samples	(Figure	14E,	G,	 I).	These	three	
































































































































3.3.3  Natural Healing (Control) and Healing with Bio-Oss® and Bio-Gide® (Test) - 




3.3.3.1 RANK/RANKL/OPG mRNA Expression 
	
RANK	mRNA	expression	increased	steadily	over	the	three	healing	time	points	for	both	
the	 control	 and	 test	 groups.	 At	 4	 weeks	 the	 level	 of	 RANK	 mRNA	 expression	 was	
significantly	 lower	 in	 the	 test	 group	 compared	 to	 the	 control	 group	 (‑4.26‑fold	
test/control;	 p=0.02).	 However,	 by	 8	 weeks	 the	 level	 of	 RANK	 expression	 in	 the	 test	
group	had	increased	compared	to	the	control	group	(4.54‑fold	test/control;	p=0.42).	By	
16	 weeks	 mRNA	 expression	 of	 RANK	 decreased	 in	 the	 test	 group	 compared	 to	 the	
control	group	(‑2.19‑fold	test/control;	p=0.28).	(Figure	16)	
		












































3.3.3.2 Expression of Msx2 and Sp7  
 
At	4	weeks	Msx2	expression	level	increased	in	the	control	group	compared	to	the	test	
group	 (‑5.46‑fold	 test/control;	 p=0.11).	 However,	 by	 8	 weeks	 the	 expression	 levels	







(1.55‑fold	 test/control;	 p=0.34	 and	 1.79‑fold	 test/control;	 p=0.66, respectively).	
Expression	level	of	Sp7	significantly	decreased	in	the	test	group	compared	to	the	control	
at	 16	 weeks	 (‑2.89‑fold	 test/control;	 p=0.04)	 (Figure	 19B,	 Table	 8).	 Initial	 lower	
expression	 levels	 of	 Sp7	 compared	 to	 MSX2	 were	 found,	 with	 similar	 levels	 for	 the	
control	and	test	groups.		
	





























3.3.4  Differential mRNA expression (Test Group/Control Group) 
 
Both	RANK	and	MSX2	expression	level	was	decreased	in	the	test	group	when	compared	
to	 the	 control	 group	 at	 4	 and	 16	 weeks,	 and	 this	 was	 statistically	 significant	 for	











Table 8: Differential	mRNA	expression 
*p-value <0.05	
Genes 













RANK	 ‑4.26	 0.02*	 4.54	 0.43	 ‑2.19	 0.28	
RANKL	 1.44	 0.75	 1.00	 >0.99	 ‑1.04	 0.96	
OPG	 3.00	 0.07	 1.00	 >0.99	 150.53	 0.38	
Col1A1	 1.05	 0.90	 3.04	 0.50	 ‑1.64	 0.41	
TIMP3	 6.67	 0.29	 6.05	 0.30	 ‑2.89	 0.18	
Sp7	 1.55	 0.34	 1.79	 0.66	 ‑2.89	 0.04*	
Msx2	 ‑5.46	 0.11	 1.53	 0.73	 ‑1.82	 0.36	
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Chapter 4 Discussion  
4.1 Overview  
 
Histological	assessment	of	alveolar	sockets	preserved	with	the	particulate	xenograft	Bio‑




disproven;	 although	 the	 key	 markers	 of	 osteogenesis,	 RANK,	 RANKL	 and	 OPG	 were	
present	 and	 mRNA	for	 key	regulators	 of	osteoblast	differentiation	were	expressed	 in	
healing	 tooth	 sockets,	 grafting	 with	 bone	 xenograft	 (Bio‑Oss®)	 and	 resorbable	
membrane	(Bio‑Gide®)	did	not	change	this	 in	any	marked	 fashion.	Test	 (grafted)	and	
control	 (un‑grafted)	 groups	 were	 comparable	 at	 all	 time	 points,	 except	 for	 RANK	




4.2 RANK, RANKL and OPG Axis 
 
To	 the	 best	 of	 the	 investigator’s	 knowledge,	 this	 is	 the	 first	 large	 animal	 model	 to	
evaluate	 RANK,	 RANKL	 and	 OPG	 expression	 during	 natural	 and	 grafted	 tooth	 socket	
healing.	The	balance	between	bone	formation	and	resorption	is	maintained	by	the	RANK,	
RANKL	 and	 OPG	 axis.	 RANKL	 is	 expressed	 by	 osteoblasts	 and	 when	 it	 binds	 to	 its	
receptor	RANK	on	the	surfaces	of	pre‑osteoclasts	the	process	of	osteoclastogenesis	 is	




















stimulating	 the	 differentiation	 and	 activation	 of	 osteoclasts	 and	 thus	 controlling	 the	 modelling	 and	
remodelling	of	bone.	OPG	is	an	antagonistic	endogenous	receptor	that	binds	and	removes	RANKL	and	






control	 and	 test	 groups	 over	 all	 time	 points,	 suggesting	 that	 the	 rate	 of	 osteoclastic	


























using	 magnesium‑enriched	 hydroxyapatite	 (MgHA)	 graft.	 In	 the	 present	 study,	 the	
protein	expression	of	OPG	was	similar	in	control	and	test	groups	over	time,	and	in	both	
groups	strong	staining	of	OPG	was	associated	with	osteoclasts.	Canullo	and	colleagues	




A	 clinical	 study	 of	 histological	 healing	 and	 gene	 expression	 in	 maxillary	 sinus	 floor	
augmentation	 (MSFA)	 with	 Bio‑Oss®,	 compared	 with	 healed	 posterior	 alveolar	 ridge,	
found	no	difference	in	RANKL	and	OPG	mRNA	expression	after	six	months	(Suwanwela	
et	al.,	2017).	Histologically	the	MSFA	region	showed	similar	healing	to	the	present	study	
with	 new	 bone	 and	 fibrous	 tissue	 formation,	 however,	 this	 was	 not	 compared	 to	
naturally	healed	tooth	sockets.	Overall,	histological	findings	have	shown	xenografts	are	
replaced	with	new	bone	without	a	detectable	associated	change	in	gene	expression.	In	a	
similar	 clinical	 study,	 sinus	 augmentation	 was	 carried	 using	 either	 autologous	 bone	
particles	or	MgHA.	At	five	months	of	healing,	decreased	mRNA	expression	of	RANKL	was	
present	 in	 the	 MgHA	 group	 with	 comparable	 expression	 of	 OPG	 in	 both	 groups.	 The	
lower	RANKL/	OPG	ratio	indicated	reduced	osteoclastogenic	activity	in	the	presence	of	
grafting	materials	as	evident	by	comparable	levels	of	bone	volume	(Crespi	et	al.,	2009).	
In	 the	 present	 study,	 the	 grafted	 sockets	 showed	 decreased	 expression	 of	 RANKL	
compared	to	the	control	group.			
A	 rabbit	 study	 has	 been	 undertaken	 with	 implants	 placed	 in	 the	 tibia	 and	 the	 gaps	
between	 the	 implant	 and	 bone	 either	 filled	 with	 blood	 clot,	 Bio‑Oss®	 or	 Bio‑Oss®	
collagen	(Dos	Santos	et	al.,	2016).	Histological	and	gene	expression	analysis	were	carried	
out	 at	 15,	 30	 and	 60	 days.	 OPG	 mRNA	 expression	 increased	 over	 time	 with	 higher	









in	 the	 immunohistochemical	 images	 of	 OPG	 protein	 expression.	 The	 findings	 of	 the	
present	study	are	not	consistent	with	the	study	by	Dos	Santos	colleagues	(2016)	who	
reported	 higher	 protein	 expression	 of	 OPG	 and	 RANKL	 in	 Bio‑Oss®	 grafted	 group	
compared	to	natural	healing.	The	mRNA	and	protein	expression	of	RANKL	in	the	present	




spontaneous	 healing	 compared	 to	 the	 Bio‑Oss®	 and	 Bio‑Gide®	 grafted	 sockets.	
Osteoclastic	 activity	 was	 evident	 with	 the	 detection	 of	 RANKL	 and	 RANK	 mRNA	 and	
protein	 expression	 indicative	 of	 bone	 resorption	 occurring	 in	 both	 groups	 over	 time.	
When	 RANKL	 and	 RANK	 expression	 are	 considered	 collectively,	 there	 appears	 to	 be	
more	 bone	 resorption	 in	 the	 test	 group	 suggesting	 decreased	 healing	 at	 8	 weeks,	
however	 by	 16	 weeks	 the	 levels	 were	 comparable.	 Bone	 formation	 activity	 as	
determined	by	OPG	mRNA	and	protein	expression,	was	also	shown	to	be	comparable	in	
both	groups.			
The	 histological	 findings	 of	 the	 present	 study	 are	 similar	 to	 a	 number	 of	 previously	
published	 studies	(Canullo	et	al.,	2016;	 Dos	Santos,	 et	al.,	 2016;	Canciani	 et	al.,	 2017;	
Suwanwela	 et	 al.,	 2017);	 the	 current	 study	 however,	 has	 endeavoured	 to	 also	
quantitatively	analyse	the	level	of	mRNA	expression	of	key	osteogenic	regulators.	
 















filled	 with	 Bio‑Oss®	 plus	 hypoxia‑inducible	 factor	 (HIF)‑1α	 protein	 versus	 Bio‑Oss®	
alone,	 in	 a	 dog	 model.	 At	 12	 weeks	 of	 healing	 the	 mRNA	 expression	 of	 Sp7	 for	 both	
grafted	sockets	was	higher	than	the	naturally	healing	sockets	(Tan	et	al.,	2019).	
Msx2	 is	 a	 marker	 for	 osteoblast	 differentiation	 and	 hence	 plays	 an	 essential	 role	 in	
osteogenesis	(Ichida	et	al.,	2004).	Msx2	mRNA	expression	increased	over	all	time	points	
in	both	the	control	and	test	groups.	Msx2	mRNA	expression	was	lower	in	the	sockets	
grafted	 with	 Bio‑Oss®	 compared	 to	 naturally	 healing	 sockets	 at	 4	 and	 16	 weeks,	




As	 Sp7	 expression	 is	 induced	 directly	 by	 Msx2	 (Matsubara	 et	 al.,	 2008),	 when	 the	
expression	levels	of	Sp7	and	Msx2	together	are	considered,	the	expression	level	of	these	





in	 the	 present	 study	 increased	 steadily	 in	 the	 natural	 healing	 socket.	 In	 the	 sockets	







becomes	 more	 apparent	 when	 Col1A1	 and	 TIMP3	 mRNA	 expression	 are	 considered	
collectively.	 Col1A1	 is	 a	 marker	 of	 ECM	 and	 TIMP3	 which	 are	 associated	 with	
remodelling;	both	increased	in	the	early	phase	of	healing	in	the	grafted	sockets.	It	can	be	
hypothesised	 that,	 despite	 being	 not	 statistically	 significant,	 ECM	 may	 be	 laid	 down	
earlier	in	the	grafted	sockets	due	to	the	scaffolding	role	of	Bio‑Oss®.		
	














the	sheep	mandible	as	a	good	model	 for	 the	evaluation	of	healing	 in	 a	 grafted	defect.	
More	recently,	the	sheep	mandible	model	has	been	used	to	examine	healing	in	extraction	
























human	 extraction	 sockets	 between	 12	 and	 24	 weeks	 report	 the	 presence	 of	 lamellar	





4.4.2  Effects of Full Thickness Flap Elevation on Socket Healing  
	
In	 our	 study,	 full	 thickness	 flaps	 were	 elevated	 prior	 to	 the	 extractions	 and	 primary	
closure	 was	 achieved	 for	 both	 non‑grafted	 and	 grafted	 sockets.	 There	 is	 conflicting	




















consensus	 regarding	 the	 preference	 of	 one	 technique	 over	 the	 other.	 In	 our	 study	 a	
flapped	 approach	 was	 used	 to	 facilitate	 extraction	 of	 teeth	 using	 minimal	 trauma	
without	bone	removal	and	tooth	sectioning.	In	terms	of	level	of	difficulty	for	extraction	
of	 teeth	 in	 humans	 and	 sheep,	 tooth	 extractions	 in	 sheep	 are	 very	 laborious	 and	
technique	sensitive.	Using	a	flapped	approach	was	also	a	suitable	approach	in	sheep	as	
they	are	ruminants	with	continuous	mastication	and	their	diets	can	be	fibrous,	therefore,	
primary	 closure	 was	 indicated	 to	 help	 stabilise	 the	 bone	 graft	 and	 membrane	 in	 the	
socket.		
 















using	 xenograft	 and	 collagen	 membrane	 and	 found	 the	 dimensional	 changes	 for	 the	
single	and	multiple	extractions	sites	were	similar	(Al‑Hamoudi	et	al.,	2015).		
	
4.4.4  Animal Heterogeneity   
 
The	 animals	 used	 in	 this	 study	 were	 commercially	 sourced	 and	 were	 not	 bred	
specifically	for	research	purposes.	The	present	study	used	a	larger	number	of	animals	
than	previously	used	 in	other	studies,	 it	 is	 therefore	necessary	to	 consider	 this	when	
healing	 is	compared	between	control	and	test	groups.	Animal	heterogeneity	 is	 in	 fact	












Cardaropoli	 et	 al.,	 2003),	 monkeys	 (Scala	 et	 al.,	 2014)	 and	 the	 classic	 human	 study	
(Amler,	1969).		
The	 sheep	 model	 has	 been	 used	 for	 many	 years	 to	 examine	 tooth	 extraction	 wound	
healing.	Harrison	described	that	bone	formation	can	start	from	early	as	six	days	in	sheep	
post‑extraction	 (Harrison,	 1943).	 Socket	 extraction	 in	 sheep	 model	 and	 ridge	








aspects	 extending	 into	 the	 centre	 of	 the	sockets	were	reported	 (Liu	et	 al.,	2016).	For	
sockets	grafted	with	xenograft,	particles	of	the	biomaterials	were	in	close	proximity	with	
woven	 and	 lamellar	 bone	 after	 12	 to	 16	 weeks	 of	 healing.	 	 However,	 in	 our	 study,	
minimal	 to	no	 xenograft	particles	were	observed	 in	 the	 defects	 from	 as	 early	 as	 four	
weeks	of	healing.	
In	a	dog	model,	non‑grafted	extraction	sockets	have	been	observed	and	compared	with	
sockets	 grafted	 with	 Bio‑Oss®	 collagen,	 with	 more	 woven	 bone	 in	 the	 non‑grafted	
sockets	 at	 two	 weeks	 compared	 to	 grafted	 sockets	 (Araujo	 &	 Lindhe,	 2009).	 A	 direct	
comparison	 cannot	 be	 made	 as	 our	 earliest	 time	 point	 was	 four	 weeks.	 The	 authors	
suggested	that	the	grafting	material	actually	delayed	healing	in	the	early	phases.	Similar	




tooth	 extraction,	 the	 residual	 periodontal	 ligament	 (PDL)	 in	 the	 apical	 region	 of	 the	
defect	 can	 retain	 some	 vitality	 and	 migrate	 into	 the	 provisional	 matrix	 during	 early	
healing.	 In	 our	 study,	 the	 socket	 sizes	 were	 standardised	 using	 implant	 burs,	 which	
would	have	removed	any	remaining	PDL	and	consequently	may	have	affected	healing.	
	
4.5.1  Behaviour of Grafting Materials in Alveolar Sockets in Sheep 
 
Histological	 assessments	 of	 the	 grafted	 sockets	 in	 our	 study	 found	 that	 little	 grafting	
material	remained	in	the	sockets	over	time.		Histological	evidence	from	studies	where	
biomaterials	have	been	placed	in	healing	sites	have	shown	that	they	can	cause	a	foreign	
body	reaction	that	activates	osteoclastic	cells,	 resulting	 in	 the	removal	of	 the	grafting	
material	 (Rasperini	 et	 al.,	 2010;	 Sisti	 et	 al.,	 2012).	 This	 could	 explain	 why	 limited	
amounts	 of	 grafting	 materials	 were	 observed	 in	 the	 sockets.	 Increased	 activity	 of	




made	 up	 of	 woven	 bone,	 parallel‑fibered	 bone,	 lamella	 bone	 and	 graft	 particles	 was	
present	over	the	defect	entrance,	demonstrating	that	the	xenograft	did	not	prevent	bone	





collagen)	 have	 been	 evaluated	 in	 a	 series	 of	 dog	 model	 studies	 (Araujo	 et	 al.,	 2009;	
Araujo	 &	 Lindhe,	 2009).	 	 At	 two	 weeks	 of	 healing,	 there	 were	 no	 xenograft	 particles	
present	in	the	apical	portion	of	the	defect	with	minimal	amounts	of	woven	bone	present	






the	 healing	process.	 This	 scaffolding	role	of	 biomaterials	 like	 Bio‑Oss®	does	 however	
reduce	the	dimensional	changes	that	occur	during	healing	of	extraction	sockets.		
One	research	group	has	reported	large	numbers	of	base	multicellular	units	(BMUs)	in	
grafted	 sockets	 compared	 to	 non‑grafted	 sockets	 in	 a	 dog	 model	 (Buckwalter	 et	 al.,	
1995).	 BMUs	 were	 present	 at	 sites	 where	 active	 modelling/remodelling	 takes	 place,	
















4.6 Immunohistochemistry – Discussion of Methodology  
 
  Decalcification and Paraffin Embedding  
	
Histological	 assessment	 of	 mineralised	 tissue	 requires	 decalcification	 for	 removal	 of	
calcium	 ions/salts	 prior	 to	 paraffin	 embedding	 and	 staining.	 The	 process	 of	





colleagues	 (2017)	 10%	 EDTA	 at	 room	 temperature	 is	 the	 gold	 standard	 that	 gives	
optimal	cellular	and	structural	morphology.	The	decalcification	time	using	10%	EDTA	
can	 be	 shortened	 by	 increasing	 the	 temperature	 of	 EDTA	 from	 room	 temperature	 to	
37°C,	however,	this	has	adverse	effects	on	soft	tissue	morphology.	Decalcification	with	
5%	nitric	acid	and	10%	formic	acids	has	been	shown	to	be	faster	than	EDTA,	however	







from	 the	 amount	 of	 woven	 bone,	 another	 factor	 that	 may	 have	 contributed	 to	 the	
variation	was	the	different	sizes	of	the	alveolar	sockets.	The	size	of	premolar	sockets	in	
sheep	 increases	 from	 anterior	 to	 posterior,	 therefore,	 third	 premolar	 sockets	 were	
larger	than	the	first	and	second	premolars.	It	has	been	suggested	that	the	duration	of	
decalcification	 process	 can	 be	 shortened	 in	 larger	 animals	 such	 as	 dogs,	 sheep	 and	
horses	by	cutting	the	specimens	into	smaller	sequential	sections	(Schmitz	et	al.,	2010).	
















opened	 for	 longer	 than	 a	 week)	 could	 have	 negatively	 affected	 tissue	 adherence	
(Gambella	et	al.,	2017).	In	terms	of	the	brand	of	slides,	Superfrost®	slides	was	reported	
to	lessen	tissue	detachment	compared	to	HistoBond®	(Gambella	et	al.,	2017).	Formalin	
fixation	 of	 48	 hours	 compared	 to	 24	 hours	 reduced	 tissue	 detachment	 significantly.	
Overall,	tissue	fixation	in	formalin	for	24	hours	for	small	samples	to	48	hours	for	larger	
samples	 is	 standard	 practice	 and	 has	 shown	 to	 result	 in	 less	 tissue	 detachment	
(Gambella	et	al.,	2017).	
Heat	induced	epitope	retrieval	(HIER)	and	proteolytic	enzyme‑induced	epitope	retrieval	
(PIER)	 protocols	 are	 often	 used	 in	 IHC	 protocols	 for	 formalin‑fixed	 and	 paraffin	
embedded	tissues.	Suurmeijer	and	Boon	(1993)	described	the	mechanisms	of	antigen	
retrieval,	 that	 included	 breaking	 down	 cross‑linking	 between	 epitopes	 of	 unrelated	











A	 heat	 antigen	 retrieval	 method	 was	 not	 required	 for	 OPG	 as	 there	 were	 minimal	








4.6.3  Antibody Selection and Optimisation 
 
Antibodies	used	in	previous	studies	can	be	divided	into	three	categories;	well‑known	





mouse,	 however,	 during	 trials	 it	 was	 observed	 that	 there	 was	 a	 lot	 of	 non‑specific	
staining	 which	 made	 it	 difficult	 to	 differentiate	 test	 slides	 from	 negative	 controls.	 A	












and	 rabbit	 anti‑human	 respectively	 and	 these	 were	 found	 to	 give	 lower	 background	
staining.	As	highlighted	by	Archarya	and	colleagues	(2017),	the	sequences	were	aligned	
on	NCBI	thus	confirming	the	correct	protein	was	being	detected.		
Negative	 controls	 are	 an	 integral	 aspect	 of	 IHC	 protocol	 as	 antibody	 or	 non‑specific	
binding	 and	 lack	 of	 secondary	 antibody	 specificity	 can	 lead	 to	 false‑positive	 staining	






4.7 Gene Analysis – Discussion of Methodology  
 
  Tissue Homogenisation  
	






recovered	 easily	 for	 RNA	 extraction.	 A	 high	 quality	 and	 quantity	 of	 RNA	 was	 then	
extracted.	
		





















the	 radiograph	 over	 the	 mandible	 and	 aligned	 with	 landmarks	 around	 the	 teeth	 and	
bone.	The	premolar	socket	outlines	were	marked	on	the	mandible	and	sectioned	using	a	
saw.	A	similar	method	of	socket	sectioning	was	used	by	Lander	and	colleagues	(2016).	
Some	 angulation	 and	 distortions	 did	 arise	 from	 the	 radiographic	 step	 which	 made	





the	 study	 without	 getting	 dislodged	 or	 lost.	 Another	 method	 to	 ensure	 accuracy	 in	
sectioning	 individual	 sockets	 would	 be	 to	 take	 impressions	 of	 the	 teeth	 prior	 to	
extractions	 and	 construct	 stents	 for	 individual	 sheep.	 However,	 this	 method	 will	
increase	operative	time	and	add	additional	cost,	especially	with	large	sample	sizes.			






used	 in	 this	 study.	 Apart	 from	 the	 use	 of	 stents,	 three‑dimensional	 computed	







4.9  Conclusions and Clinical Significance   
 











4.9.2  Clinical Significance  
 
Soft	and	hard	tissue	remodelling	is	a	natural	response	in	natural	healing	of	extraction	
sockets.	 The	 remodelling	 process	 can	 lead	 to	 40‑60%	 dimensional	 changes	 in	 the	



























axis	 plays	 a	 key	 role	 in	 healing	 and	 remodelling	 of	 extraction	 sockets.	 Within	 its	
limitations,	the	present	study	has	shown	that	healing	at	a	molecular	level,	as	shown	by	
the	expression	of	key	osteogenic	markers	and	regulators	of	osteoclast	differentiation,	
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Appendix I: Sample Processing  
1. Randomization (Latin Square) for Treatment Allocation  
 
Surgery No. Sheep No. Group R P1 R P2 R P3 
1	 597	 4‑	week	 A	 B	 C	
2	 437	 4‑week	 B	 C	 A	
3	 432	 4‑week	 C	 A	 B	
4	 586	 4‑week	 A	 B	 C	
5	 590	 4‑week	 B	 C	 A	
6	 441	 4‑week	 C	 A	 B	
7	 583	 4‑week	 A	 B	 C	
8	 593	 4‑week	 B	 C	 A	
9	 428	 4‑week	 C	 A	 B	
10	 595	 4‑week	 A	 B	 C	
11	 440	 8‑week	 A	 B	 C	
12	 594	 8‑week	 B	 C	 A	
13	 589	 8‑week	 C	 A	 B	
14	 434	 8‑week	 A	 B	 C	
15	 591	 8‑week	 B	 C	 A	
16	 598	 8‑week	 C	 A	 B	
17	 426	 8‑week	 A	 B	 C	
18	 439	 8‑week	 B	 C	 A	
19	 438	 8‑week	 C	 A	 B	
20	 450	 8‑week	 A	 B	 C	
21	 430	 16‑week	 A	 B	 C	
22	 436	 16‑week	 B	 C	 A	
23	 599	 16‑week	 C	 A	 B	
24	 584	 16‑week	 A	 B	 C	
25	 587	 16‑week	 B	 C	 A	
26	 585	 16‑week	 C	 A	 B	
27	 442	 16‑week	 A	 B	 C	
28	 592	 16‑week	 B	 C	 A	
29	 427	 16‑week	 C	 A	 B	












Group R P3 
1	 597	 4‑week	 C	
2	 432	 4‑week	 B	
3	 586	 4‑week	 C	
4	 441	 4‑week	 B	
5	 583	 4‑week	 C	
6	 428	 4‑week	 B	
7	 595	 4‑week	 C	
8	 440	 8‑week	 C	
9	 589	 8‑week	 B	
10	 434	 8‑week	 C	
11	 598	 8‑week	 B	
12	 426	 8‑week	 C	
13	 438	 8‑week	 B	
14	 450	 8‑week	 C	
15	 430	 16‑week	 C	
16	 599	 16‑week	 B	
17	 584	 16‑week	 C	
18	 585	 16‑week	 B	
19	 442	 16‑week	 C	
20	 427	 16‑week	 B	
21	 425	 16‑week	 C	








Appendix II: Buffer Preparation  
 

































































































































Appendix III: Immunohistochemistry  
 


























Step No. Reagent Hold/ Use 
Temperature 
Time (min) 
1. Formalin	 Ambient	 30	
2. Formalin	 Ambient	 30	
3. Alcohol	 Ambient	 60	
4. Alcohol	 Ambient	 60	
5. Alcohol	 Ambient	 60	
6. Alcohol	 Ambient	 60	
7. Alcohol	 Ambient	 60	
8. Alcohol	 Ambient	 90	
9. Xylene	 Ambient	 60	
10. Xylene	 Ambient	 60	
11. Xylene	 Ambient	 90	
12. Wax	 62°C	 60	
13. Wax	 62ᴼC	 60	
14. Wax	 62ᴼC	 30	
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Slide # Slide Type Temperature Code 
1	 Superfrost	Ultra	Plus®	 Heat	(60°C)	 A/	heat	
2	 Superfrost	Ultra	Plus®	 Heat	(60°C)	 B/	heat	
3	 Superfrost	Ultra	Plus®	 Room	temperature	 A/	RT	




2. De‑wax	and	rehydrate	tissue	sections	(Xylene (HSNO, Batch #: 1701236660, Cat #: 

















































Sequence No. Reagent Time 
1.  Xylene	 1	minute	
2.  Xylene	 30	seconds 
3.  Xylene	 30	seconds 
4.  Absolute	Alcohol	 30	seconds 
5.  Absolute	Alcohol	 30	seconds 
6.  Absolute	Alcohol	 30	seconds 
7.  Absolute	Alcohol	 30	seconds 
8.  Absolute	Alcohol	 30	seconds 
9.  Absolute	Alcohol	 30	seconds 
10.  Absolute	Alcohol	 30	seconds 
11.  Absolute	Alcohol	 30	seconds 
12.  Running	water	 30	seconds 
13.  Gill’s	No.	2	Haematoxylin	 1	minute	
14.  Running	water	 30	seconds	
15.  Scott’s	tap	water	 30	seconds	
16.  Running	water	 30	seconds	
17.  Eosin	 1	minute	30	seconds	
18.  Running	water	 30	seconds	
19.  Absolute	Alcohol	 30	seconds	
20.  Absolute	Alcohol	 30	seconds	
21.  Xylene	 30	seconds	
22.  Xylene	 30	seconds	
23.  Xylene	 30	seconds	
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 Equal	 parts	 of	 Weigert’s	 (A)	 and	 Weigert’s	 (B)	 were	 mixed	 and	 slides	 were	
stained	with	working	Weigert’s	 Iron	Hematoxylin	 for	5	mins.	Slides	were	then	
rinsed	in	running	tap	water	for	2	mins	













5. Immunohistochemistry Protocols 
A. OPG   
	






























































































































































































































Staining		 Ab diluent:	5% rabbit serum	+	1% BSA/ PBS		
Ab	diluent	required	= 3000 µl	(150	µl	5%	rabbit	
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C. RANKL  
 


























































































































































































































D. RANK  
 












































































































































































































































































Apply	diluent	Rabbit IgG Control 
5	µg/ml	RANKL:	3000	µl	(1:	200	dilution)			















































































































6. Slide Scoring  
Slide	Scoring.	For	RANK/	RANKL	positive	staining	were	scored	as	+	(1‑2	positive	osteoclasts	per	section),	







Cell or Tissue 
Type 
RANK RANKL OPG 
Control Test Control Test Control Test 
4	Weeks	
Osteoclasts	 	 	 	 	 	 	
Osteoblasts	 	 	 	 	 	 	
Connective	tissue	 	 	 	 	 	 	
Time 
Points	
Cell or Tissue 
Type	
Control Test Control Test Control Test 
8	Weeks	
Osteoclasts	 	 	 	 	 	 	
Osteoblasts	 	 	 	 	 	 	
Connective	tissue		 	 	 	 	 	 	
Time 
Points	
Cell or Tissue 
Type	
Control Test Control Test Control Test 
16	
Weeks	
Osteoclasts	 	 	 	 	 	 	
Osteoblasts		 	 	 	 	 	 	
Connective	tissue		 	 	 	 	 	 	
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Appendix IV: Gene Analysis 
 






Group R P3 Concentration 
of RNA 
(ng/µl) 
A260  A260/ 
A280  
1. 	 597	 4‑week	 C	 18.4	 0.045	 1.704	
2. 	 432	 4‑week	 B	 60.4	 0.198	 1.756	
3. 	 586	 4‑week	 C	 128.0	 0.320	 1.899	
4. 	 441	 4‑week	 B	 59.6	 0.149	 1.886	
5. 	 583	 4‑week	 C	 11.2	 0.028	 1.556	
6. 	 428	 4‑week	 B	 36.4	 0.091	 1.820	
7. 	 595	 4‑week	 C	 32.8	 0.081	 1.745	
8. 	 440	 8‑week	 C	 19.6	 0.047	 1.750	
9. 	 589	 8‑week	 B	 34.0	 0.085	 1.771	
10. 	 434	 8‑week	 C	 13.2	 0.031	 1.833	
11. 	 598	 8‑week	 B	 14.0	 0.035	 1.667	
12. 	 426	 8‑week	 C	 60.8	 0.152	 1.831	
13. 	 438	 8‑week	 B	 62.8	 0.158	 1.847	
14. 	 450	 8‑week	 C	 67.2	 0.169	 1.888	
15. 	 430	 16‑week	 C	 129.0	 0.324	 1.878	
16. 	 599	 16‑week	 B	 38.4	 0.096	 1.846	
17. 	 584	 16‑week	 C	 47.2	 0.119	 1.872	
18. 	 585	 16‑week	 B	 24.4	 0.061	 1.848	
19. 	 442	 16‑week	 C	 21.2	 0.053	 1.828	
20. 	 427	 16‑week	 B	 19.2	 0.048	 1.778	
21. 	 425	 16‑week	 C	 37.6	 0.095	 1.843	
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2. cDNA Synthesis  
 
Step 1: SuperScript	IV	VILO	Master	Mix	with	ezDNase	Enzyme	reaction	setup 
 
Tube # 












8	 4.9	 2.3	 5	 8	 8	 8	 8	 8	 8	 4.9	 4.8	 4.5	 2.3	 8	 6.3	 8	 8	 8	
Nuclease‑
free	water 
0	 3.1	 5.7	 3	 0	 0	 0	 0	 0	 0	 3.1	 3.2	 3.5	 5.7	 0	 1.7	 0	 0	 0	





















1 2 3 4 5 6 7 8 9 11 12 13 14 15 16 17 18 20 21 
Reaction 
mix	from	
Step	1 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	
Mastermix	
Step	2 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	 10	
	 20	 20	 20	 20	 20	 20	 20	 20	 20	 20	 20	 20	 20	 20	 20	 20	 20	 20	 20	
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using	 the	 clustalo	 alignment	 tool	 at	 www.ebi.ac.uk/Tools/msa/clustalo/.	 The	
alignment	file	was	downloaded.	Forward	and	reverse	primers	were	identified	using	
Primer	Premier	5.0	software	and	the	sheep	FASTA	mRNA	sequence.	The	size	of	the	
amplification	 product	 size	 was	 confined	 to	 5‑160bps.	 The	 complete	 primer	 was	











































































































































































































































































































lcl|AF018253.1_cds_AAB86809.1_1              ATGGCCCCGCGCGCCCGGCGGCGCCGCCCGCTGTTCGCGCTGCTGCTGCTCTGCGCGCTG 60 
lcl|XM_010819019.3_cds_XP_010817321.1_1      ------------------------------------------------------------ 0 
lcl|XM_012147022.1_cds_XP_012002412.1_1      ATGGCCCTGCGCGCCCGGCGGCGCCGCCCGCTGCCCGCGCCGCTGGCGCTGCTGGCGCTG 60 
                                                                                                          
 
lcl|AF018253.1_cds_AAB86809.1_1              CTCGCCCGGCTGCAGGTGGCTTTGCAGATCGCTCCTCCATGTACCAGTGAGAAGCATTAT 120 
lcl|XM_010819019.3_cds_XP_010817321.1_1      ------ATGTTCAGGGTGACTTTGCAGATCACCCCTCCATGTACCAGCGAGAGGTATTAC 54 
lcl|XM_012147022.1_cds_XP_012002412.1_1      CTCGGCCGGCTGCAGGTGACTTTGCAGATCACCCCTCCGTGTACCAGCGAGAGGCATTAC 120 
                                                     * *   **** *********** * ***** ******** **** * ****  
 
lcl|AF018253.1_cds_AAB86809.1_1              GAGCATCTGGGACGGTGCTGTAACAAATGTGAACCAGGAAAGTACATGTCTTCTAAATGC 180 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GAGCATCTTGGACAATGCTGTAAGAAATGTGAGCCAGGAACATACATGTCTTCCAAATGC 114 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GAGCATCTTGGACAATGCTGTAAGAAATGTGAGCCAGGAACGTACATGTCTTCCAAATGC 180 
                                             ******** ****  ******** ******** *******  *********** ****** 
 
lcl|AF018253.1_cds_AAB86809.1_1              ACTACTACCTCTGACAGTGTATGTCTGCCCTGTGGCCCGGATGAATACTTGGATAGCTGG 240 
lcl|XM_010819019.3_cds_XP_010817321.1_1      ACCACTACGTCTGAGAGCGTCTGTCTGCCCTGTGGCTTGGACGAGTACCTGGACACCTGG 174 
lcl|XM_012147022.1_cds_XP_012002412.1_1      ACCACTACCTCTGAGAGCGTCTGTCTGCCCTGCGGCTTGGACGAATACCTGGACACCTGG 240 
                                             ** ***** ***** ** ** *********** ***  *** ** *** **** * **** 
 
lcl|AF018253.1_cds_AAB86809.1_1              AATGAAGAAGATAAATGCTTGCTGCATAAAGTTTGTGATACAGGCAAGGCCCTGGTGGCC 300 
lcl|XM_010819019.3_cds_XP_010817321.1_1      AATGAAGAAGATAAATGCTTGCTGCACAAAGTCTGCGACCCAGGCAAGGCCCTGAGGGCC 234 
lcl|XM_012147022.1_cds_XP_012002412.1_1      AACGAAGAAGATAAATGCTTACTGCACAAAGTCTGCGACCCAGGCAAGGCCCTGAGGGCG 300 
                                             ** ***************** ***** ***** ** **  **************  ***  
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lcl|AF018253.1_cds_AAB86809.1_1              GTGGTCGCCGGCAACAGCACGACCCCCCGGCGCTGCGCGTGCACGGCTGGGTACCACTGG 360 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GTGGAGCCCGGCAACCGGACGGCGCCGCGCCGCTGCGCCTGCACCGCCGGCTACCACTGG 294 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GTGGAGCCCGGCAACCGGACGGCGCCGCGCCGCTGCGCCTGCACGGCCGGCTACCACTGG 360 
                                             ****   ******** * *** * ** ** ******** ***** ** ** ********* 
 
lcl|AF018253.1_cds_AAB86809.1_1              AGCCAGGACTGCGAGTGCTGCCGCCGCAACACCGAGTGCGCGCCGGGCCTGGGCGCCCAG 420 
lcl|XM_010819019.3_cds_XP_010817321.1_1      AGCGAGGACTGCCGCTGCTGCACCCGCAACGCCGAGTGCGCGCGCGGCTTCGGCGCCCGG 354 
lcl|XM_012147022.1_cds_XP_012002412.1_1      AGCGAGGACTGCCGCTGCTGCAGCCGGAACGCCGAGTGCGCGCGCGGCTTCGGCGCCCGG 420 
                                             *** ********   ******  *** *** ************  *** * ******* * 
 
lcl|AF018253.1_cds_AAB86809.1_1              CACCCGTTGCAGCTCAACAAGGACACAGTGTGCAAACCTTGCCTTGCAGGCTACTTCTCT 480 
lcl|XM_010819019.3_cds_XP_010817321.1_1      CGCCCCGTGCAGCTCAACAAGGACACGGTGTGTGAGCCCTGCCCCTCAGGCTACTTCTCC 414 
lcl|XM_012147022.1_cds_XP_012002412.1_1      CGCCCCGTGCAGCTCAACAAGGACACAGTGTGTGAGCCCTGCCCCGCAGGCTACTTCTCC 480 
                                             * ***  ******************* *****  * ** ****   *************  
 
lcl|AF018253.1_cds_AAB86809.1_1              GATGCCTTTTCCTCCACGGACAAATGCAGACCCTGGACCAACTGTACCTTCCTTGGAAAG 540 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GACACCGTTTCCGCCACAGAGACGTGCAGACCCTGGACCAACTGTACCATTCTTGGAGGG 474 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GACACCGTTTCCGCCACAGAGACGTGCAGACCCTGGACCAACTGTACCATCCTTGGACGG 540 
                                             **  ** ***** **** ** *  ************************ * ******  * 
 
lcl|AF018253.1_cds_AAB86809.1_1              AGAGTAGAACATCATGGGACAGAGAAATCCGATGCGGTTTGCAGTTCTTCTCTGCCAGCT 600 
lcl|XM_010819019.3_cds_XP_010817321.1_1      ACAGAAGTGCGTCACGGAACCGATAAATTAGATGTGGTTTGTAGTCC---TCTCCCATCT 531 
lcl|XM_012147022.1_cds_XP_012002412.1_1      ACAGAAGTGCATCACGGAACTGATAAATCAGATGTGGTTTGTAGTCG---TCCCCTACCT 597 
                                             * ** **  * *** ** ** ** ****  **** ****** ***     **  * * ** 
 
lcl|AF018253.1_cds_AAB86809.1_1              AGAAAACCACCAAATGAACCCCATGTTTACTTGCCCGGTTTAATAATTCTGCTTCTCTTC 660 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GCAAATCCATCAAATGAACCGCAGGTTTACTTGCCCAGTTTAATTATTCTGCTGCTCTTC 591 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GCAAGTTCACCGAATGAACCGCAGATTTACTTGCCCAGTCTAATCATCCTGCTCCTCTTC 657 
                                               **   ** * ******** **  *********** ** **** ** ***** ****** 
 
lcl|AF018253.1_cds_AAB86809.1_1              GCGTCTGTGGCCCTGGTGGCTGCCATCATCTTTGGCGTTTGCTATAGGAAAAAAGGGAAA 720 
lcl|XM_010819019.3_cds_XP_010817321.1_1      ATGTCTGTGGCGTTAGTAGCTGCCGTCATCTTCGGTGTTTACTACAGGAAAAAAGGGAAA 651 
lcl|XM_012147022.1_cds_XP_012002412.1_1      ACGTCTGTGGCTTTAGTAGCTGCCGTCATCTTTGGTGTTTACTACAGGAAAAAAGGGAAA 717 
188 
                                               *********  * ** ****** ******* ** **** *** *************** 
 
lcl|AF018253.1_cds_AAB86809.1_1              GCACTCACAGCTAATTTGTGGCACTGGATCAATGAGGCTTGTGGCCGCCTAAGTGGAGAT 780 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GCACTAACAGCTAATTTGTGGCACTGGGTCAATGAGGCTTGCGGCCGCCTAAATGGAAAT 711 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GCACTAACAGCTAATTTGTGGCACTGGGTCAATGAGGCTTGCGGCCGCCTAAATGGAAAT 777 
                                             ***** ********************* ************* ********** **** ** 
 
lcl|AF018253.1_cds_AAB86809.1_1              AAG---GAGTCCTCAGGTGACAGTTGTGTCAGTACACACACGGCAAACTTTGGTCAGCAG 837 
lcl|XM_010819019.3_cds_XP_010817321.1_1      AAGCAGGAGTCCGCAGGCAACAGTTTCAGCTGCACTCACGTGGAGGCCGCCAGCGCCCGC 771 
lcl|XM_012147022.1_cds_XP_012002412.1_1      AAGCAGGAGTCCGCAGGCAACAGTTTCAGCTGCACTCACGTGGAGGCCGCCAGCGCCCGC 837 
                                             ***   ****** ****  ******    * * ** ***  **    *    *    *   
 
lcl|AF018253.1_cds_AAB86809.1_1              GGAGCATGTGAAGGTGTCTTACTGCTGACTCTGGAGGAGAAGACATTTCCAGAAGATATG 897 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GAAGTCTGTGAGGGTGTCTTCCTGCTGACGCTGGAACAGAAGGTGTTTTCTGAAGACACG 831 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GAAGTCTGTGAGGGTGTCTTCCTGCTGACCCTGGAACAGAAGGTGTTTTCTGAAGACACG 897 
                                             * **  ***** ******** ******** *****  *****   *** * ***** * * 
 
lcl|AF018253.1_cds_AAB86809.1_1              TGCTACCCAGATCAAGGTGGTGTCTGTCAGGGCACGTGTGTAGGAGGTGGTCCCTACGCA 957 
lcl|XM_010819019.3_cds_XP_010817321.1_1      TGCCATCCGGAGGCGGGG------------GGCGCGTGCGCAGCGGCCTGTCCCC----- 874 
lcl|XM_012147022.1_cds_XP_012002412.1_1      TGCTGTCCGGAGGCGGGG------------GGCGCGTGCGCAGCGGCCTGTCCCC----- 940 
                                             ***   ** **    **             *** **** * **  *   *****       
 
lcl|AF018253.1_cds_AAB86809.1_1              CAAGGCGAAGATGCCAGGATGCTCTCATTGGTCAGCAAGACCGAGATAGAGGAAGACAGC 1017 
lcl|XM_010819019.3_cds_XP_010817321.1_1      -TCCGGGGAGACGCCGAGATGCTCTCCTTGGTCAGCGAG------ATCGACGGGGATCCC 927 
lcl|XM_012147022.1_cds_XP_012002412.1_1      -CCCGGGGAGACGCCGAGATGCTCTCCTTGGTCAGCGAG------ATCGAGGGGGACCCC 993 
                                                 * * *** ***  ********* ********* **      ** ** *  **   * 
 
lcl|AF018253.1_cds_AAB86809.1_1              TTCAGACAGATGCCCACAGAAGATGAATACATGGACAGGCCCTCCCAGCCCACAGACCAG 1077 
lcl|XM_010819019.3_cds_XP_010817321.1_1      TGCAGGCCAGTGCCCACGGAGGACGAATACACGGACAGGTCCCCCCGGACCGCAGACTCC 987 
lcl|XM_012147022.1_cds_XP_012002412.1_1      TGCCGGCCGGTGCCCACGGAGGACGAATACACAGACAGGCCCCCCCGGACCGCAGACTCC 1053 
                                             * * * *   ******* ** ** *******  ****** ** *** * ** *****    
 
lcl|AF018253.1_cds_AAB86809.1_1              TTACTGTTCCTCACTGAGCCTGGAAGCAAATCCACACCTCCTTTCTCTGAACCCCTGGAG 1137 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GTGGTGGCCCTCACCCCGCCTGGAGGCCGGTC------GCCCTTCCCCGAGCCCCTGGAG 1041 
189 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GTGGTGGTCCTCACCCCGCCTGGAGGCCGGTC------GCCCTTCCCCGAGCCCCTGGAG 1107 
                                              *  **  ******   ******* **   **       ** *** * ** ********* 
 
lcl|AF018253.1_cds_AAB86809.1_1              GTGGGGGAGAATGACAGTTTAAGCCAGTGCTTCACGGGGACACAGAGCACAGTGGGTTCA 1197 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GTGGGCGAGAACGACAGCTTCAGCCAGTGCTTCACGGGGACGGACAGCCTGGAGGGCTCC 1101 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GTGGGCGAGAACGACAGCTTCAGCCAGTGCTTCACGGGGACGGACAGCCTGGGGGGCTCC 1167 
                                             ***** ***** ***** ** ********************  * ***   * *** **  
 
lcl|AF018253.1_cds_AAB86809.1_1              GAAAGCTGCAACTGCACTGAGCCCCTGTGCAGGACTGATTGGACTCCCATGTCCTCTGAA 1257 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GAGAGCCCCCGCCTCCCCATGCCCCCCTGCAGGACTGCGTGGAGGCCCGCGTCCCCCAAG 1161 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GAGAGCCCCCGCCTCCCCGCGCCCCCCTGCAGGACTGCGTGGAGGCCCGCGTCCCCCAAG 1227 
                                             ** ***  *  *  * *   *****  **********  ****  ***  **** *  *  
 
lcl|AF018253.1_cds_AAB86809.1_1              AACTACTTGCAAAAAGAGGTGGACAGTGGCCATTGCCCGCACTGGGCAGCCAGCCCCAGC 1317 
lcl|XM_010819019.3_cds_XP_010817321.1_1      AAGTCCTTGCACGGAGAGGCGGGCGGCGGCCGGTGCCCGCACTGGGCAGCCGGAGCCC-- 1219 
lcl|XM_012147022.1_cds_XP_012002412.1_1      AAGTCCTTGCACGGAGAAGCGGGGGGCGGCCGGTGCCCGCACTGGGCAGCCGGCGCCC-- 1285 
                                             ** * ******   *** * **   * ****  ****************** *  **    
 
lcl|AF018253.1_cds_AAB86809.1_1              CCCAACTGGGCAGATGTCTGCACAGGCTGCCGGAACCCTCCTGGGGAGGACTGTGAACCC 1377 
lcl|XM_010819019.3_cds_XP_010817321.1_1      ----GCTCTGCAGACGGCTGTGCAGGCTGTGGGGACCTGACTTCGGGGGACCCGGCGCCC 1275 
lcl|XM_012147022.1_cds_XP_012002412.1_1      ----GCTCTGCAGTCGGCTGTGCAGGCTGCGGGGACCTGACTGCGGGGGACCCGGCGCCC 1341 
                                                  **  ****  * ***  *******  ** ***   **  ** ****   *  *** 
 
lcl|AF018253.1_cds_AAB86809.1_1              CTCGTGGGTTCCCCAAAACGTGGACCCTTGCCCCAGTGCGCCTATGGCATGGGCCTTCCC 1437 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GGACTGGAGACCCCCCCGAGTGGACCCTTGCCCCAGTGCGCCTACGGCATGGGCCTCCCG 1335 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GGCCTGGAGACCCCCCCGAGTGGACCCTTGCCCCAGTGCGCCTACGGCATGGGCCTCCCG 1401 
                                                 ***   ****     ************************* *********** **  
 
lcl|AF018253.1_cds_AAB86809.1_1              CCTGAAGAAGAAGCCAGCAGGACGGAGGCCAGAGACCAGCCCGAGGATGGGGCTGATGGG 1497 
lcl|XM_010819019.3_cds_XP_010817321.1_1      CCCGCAGCAGAC------CGGGCCGAGGCGGGGGGCCAGCCCCCGGACGGGGCCGCCGCC 1389 
lcl|XM_012147022.1_cds_XP_012002412.1_1      CCCGCAGCAGAG------CGGGCCGAGGCGGGGGGCCAGCCCCCGGACGGGGCCGCCGCC 1455 
                                             ** * ** ***        ** * *****  * * *******  *** ***** *  *   
 
lcl|AF018253.1_cds_AAB86809.1_1              AGGCTCCCAAGCTCAGCGAGGGCAGGTGCCGGGTCTGGAAGCTCCCCTGGTGGCCAGTCC 1557 
190 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GAGCTTCCCGGCCCCACGAGGGGGG------------------GCCCCGGTGACCAGCCG 1431 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GAGCTTCCCGGCCCCGCGAGGGGGG------------------GCCCCGGTGACCAGCCG 1497 
                                               *** **  ** *  ******  *                   *** **** **** *  
 
lcl|AF018253.1_cds_AAB86809.1_1              CCTGCATCTGGAAATGTGACTGGAAACAGTAACTCCACGTTCATCTCCAGCGGGCAGGTG 1617 
lcl|XM_010819019.3_cds_XP_010817321.1_1      CCTGCCTCAGGCAGTGTGACTGGAAACAGTAACTCCACGTTTATTTCCAGCGGGCAGGTG 1491 
lcl|XM_012147022.1_cds_XP_012002412.1_1      CCTGCCTCAGGCAGTGTGACTGGAAACAGTAACTCCACGTTTATTTCCAGCGGGCAGGTG 1557 
                                             ***** ** ** * *************************** ** *************** 
 
lcl|AF018253.1_cds_AAB86809.1_1              ATGAACTTCAAGGGCGACATCATCGTGGTCTACGTCAGCCAGACCTCGCAGGAGGGCGCG 1677 
lcl|XM_010819019.3_cds_XP_010817321.1_1      ATGAACTTCAAGGGCGACATCATCGTGGTCTACGTCAGTCAGAACTCGCAGGAGGGCCCG 1551 
lcl|XM_012147022.1_cds_XP_012002412.1_1      ATGAACTTCAAGGGCGACATCATCGTGGTCTACGTCAGTCAGAACTCGCAGGAGGGCCCG 1617 
                                             ************************************** **** ************* ** 
 
lcl|AF018253.1_cds_AAB86809.1_1              GCGGCG------------GCTGCGGAGCCCATGGGCCGCCCGGTGCAGGAGGAGACCCTG 1725 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GCGGGGCCGGGCGGCGGCGCGGGGGAGCCGGCGGGACGCCCGGTGCAGGAGGAGAGCTCG 1611 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GCGGGGCCGGGCGGCGGCGCGGGGGAGCCGGCGGGACGCCCGGTGCAGGAGGAGAGCCCG 1677 
                                             **** *            ** * ******   *** ******************* *  * 
 
lcl|AF018253.1_cds_AAB86809.1_1              GCGCGCCGAGACTCCTTCGCGGGGAACGGCCCGCGCTTCCCGGACCCGTGCGGCGGCCCC 1785 
lcl|XM_010819019.3_cds_XP_010817321.1_1      CCGCGCTGCGACTCGTTCGCTGGCCTCGGGCCGCGCTTCCCGGATGCGTGCGCCAGCCTC 1671 
lcl|XM_012147022.1_cds_XP_012002412.1_1      CCGAGCCGCGACTCGTTCGCCGGCCTCGGGCCGCGCTTCCCGGACGCGTGCCCCGGCCTC 1737 
                                              ** ** * ***** ***** **   *** **************  *****  * *** * 
 
lcl|AF018253.1_cds_AAB86809.1_1              GAGGG---------GCTG---------------CGGGAGCCGGAGAAGGCCTCGAGGCCG 1821 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GACGTGGGCCCAGGACTGCAGGAGTGCGGCGCCCCGGAGCCCGACAAGGCCTCGCGGCCG 1731 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GGCGTGGGCCCAGGACTGCAGGAGCGCGGCGCCCCGGCGCCCGACAAGGCCTCGCGGCCG 1797 
                                             *  *           ***               * ** *** ** ********* ***** 
 
lcl|AF018253.1_cds_AAB86809.1_1              GTGCAGGAGCAAGGCGGGGCCAAGGCTTGA------ 1851 
lcl|XM_010819019.3_cds_XP_010817321.1_1      GTGCAGGAGCAGGGGGCGGCCGAGACGCGGCGCTGA 1767 
lcl|XM_012147022.1_cds_XP_012002412.1_1      GTGCAGGAGCAGGGGGCGGCCGAGACGCGGCGCTGA 1833 
                                             *********** ** * **** ** *  *    
 Note: Yellow	highlights	selected	forward	and	reverse	primer	sequences.	
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6. qPCR Plate layout and Cq and Melting Point Results Data 
A. B2M and OPG Plate Layout with Cq Values and Melting Points  
	 Plate Layout with sample number 
B2M	
	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
	 A 432	 432	 441	 441	 428	 428	 597	 597	 583	 583	 595	 595	
	 B 589	 589	 598	 598	 438	 438	 440	 440	 426	 426	 450	 450	
	 C 599	 599	 585	 585	 427	 427	 430	 430	 584	 584	 425	 425	
	 D Water	 Water	
	 	 	 	 	 	 	 	 	 	
OPG	 E 432	 432	 441	 441	 428	 428	 597	 597	 583	 583	 595	 595	
	 F 589	 589	 598	 598	 438	 438	 440	 440	 426	 426	 450	 450	
	 G 599	 599	 585	 585	 427	 427	 430	 430	 584	 584	 425	 425	
	 H Water	 Water	
	 	 	 	 	 	 	 	 	 	
	
		 Cq Values  
B2M	 		 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
	 A 17.5	 17.6	 17.1	 17.3	 18.0	 18.0	 17.0	 17.6	 19.4	 19.5	 22.6	 23.1	
	 B 20.6	 20.9	 17.9	 18.4	 26.4	 25.9	 18.2	 18.6	 19.5	 19.9	 17.9	 18.1	
	 C 20.3	 20.7	 19.1	 19.4	 18.8	 18.8	 19.5	 19.5	 22.7	 23.0	 21.6	 21.7	
	 D 32.8	 33.7	
	 	 	 	 	 	 	 	 	 	
OPG	 E 25.0	 27.9	 25.2	 26.6	 25.5	 26.2	 28.3	 28.2	 28.4	 28.9	 34.1	 32.8	
	 F 27.4	 27.3	 27.8	 28.0	 24.1	 24.0	 24.5	 24.9	 26.6	 26.6	 24.3	 24.8	
	 G 25.4	 25.5	 28.3	 29.0	 26.5	 26.0	 25.7	 25.7	 29.7	 29.9	 28.8	 29.0	
	 H 40.0	 40.0	
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	 Melting Point 
B2M	 		 1 2 3 4 5 6 7 8 9 10 11 12 
	 A 79.1	 79.5	 79.1	 79.3	 79.2	 79.3	 79.0	 79.2	 79.2	 79.3	 79.1	 79.2	
	 B 79.2	 79.0	 79.3	 79.2	 79.4	 79.4	 79.4	 79.3	 79.2	 79.4	 79.4	 79.2	
	 C 79.5	 79.4	 79.6	 79.4	 79.5	 79.5	 79.5	 79.4	 79.7	 79.2	 79.6	 79.6	
	
D 75.4	 74.1	 	 	 	 	 	 	 	 	 	 	
OPG	 E 77.0	 76.6	 77.2	 76.8	 76.8	 76.9	 76.9	 77.2	 76.9	 77.2	 77.4	 76.4	
	 F 77.1	 77.0	 77.1	 77.1	 77.3	 77.3	 77.2	 77.1	 77.2	 77.2	 77.2	 77.3	
	 G 77.4	 77.1	 77.2	 77.2	 77.3	 77.4	 77.3	 77.3	 76.7	 77.2	 77.3	 77.1	
	 H 61.1	 61.0	
	 	 	 	 	 	 	 	 	 	
	
B. RANK and RANKL Plate Layout with Cq Values and Melting Points  
 
 Plate Layout with sample number 
 
	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
 A 432	 432	 441	 441	 428	 428	 597	 597	 583	 583	 595	 595	
RANK	 B 589	 589	 598	 598	 438	 438	 440	 440	 426	 426	 450	 450	
	 C 599	 599	 585	 585	 427	 427	 430	 430	 584	 584	 425	 425	
	 D Water	 Water	
	 	 	 	 	 	 	 	 	 	
	 E 432	 432	 441	 441	 428	 428	 597	 597	 583	 583	 595	 595	
RANKL	 F 589	 589	 598	 598	 438	 438	 440	 440	 426	 426	 450	 450	
 G 599	 599	 585	 585	 427	 427	 430	 430	 584	 584	 425	 425	
 H Water	 Water	
	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	 	 	
	
		 	 	 	  
193 
 	 	 	 	 	 	 	 	 	 	 	 	  
 Cq Values  
 
	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
 A 28.9	 28.8	 26.6	 26.6	 25.4	 24.8	 23.7	 24.1	 25.8	 25.7	 28.8	 28.9	
RANK	 B 24.9	 25.3	 23.8	 23.2	 26.4	 26.7	 21.0	 21.2	 25.2	 25.2	 25.3	 25.1	
	
C 24.4	 24.5	 23.3	 23.2	 21.8	 22.0	 24.7	 24.7	 24.8	 24.8	 23.5	 23.6	
	
D 33.0	 32.4	 	 	 	 	 	 	 	 	 	 	
	
E 29.8	 29.1	 28.8	 28.7	 25.5	 25.2	 25.7	 25.8	 28.8	 29.8	 33.2	 33.6	
RANKL	 F 28.0	 28.5	 25.6	 26.0	 30.9	 31.7	 22.2	 22.3	 28.2	 29.2	 27.3	 27.7	
 G 26.5	 26.9	 27.8	 27.3	 23.7	 23.7	 26.9	 26.8	 27.9	 28.8	 26.7	 27.2	
 H 34.3	 34.7	
	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	  
 	 	 	 	 	 	 	 	 	 	 	 	  
 Melting Point 
 
	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12 
 A 69.5	 69.5	 69.5	 69.5	 69.6	 69.8	 69.9	 69.8	 69.1	 69.7	 69.6	 69.6	
RANK	 B 69.4	 69.7	 69.8	 69.9	 70.8	 70.9	 69.2	 69.1	 69.6	 69.8	 70.0	 69.9	
	 C 69.6	 69.7	 69.8	 70.0	 69.7	 69.9	 69.9	 69.9	 70.0	 75.8	 70.0	 70.1	
	 D 69.2	 69.0	
	 	 	 	 	 	 	 	 	 	
	 E 74.0	 74.0	 73.8	 73.9	 73.8	 74.0	 74.0	 74.2	 74.1	 73.8	 72.8	 71.4	
RANKL	 F 74.1	 74.1	 74.2	 74.1	 74.8	 74.8	 74.2	 74.2	 74.2	 74.1	 74.2	 74.1	
 G 74.1	 74.1	 74.2	 74.2	 74.1	 74.3	 74.2	 74.3	 74.2	 74.1	 74.2	 74.2	
 H 71.2	 72.3	





C. Col1A1 and TIMP3 Plate Layout with Cq Values and Melting Points  
 
	 Plate Layout with sample number 
	
	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
Col1A1	 A 432	 432	 441	 441	 428	 428	 597	 597	 583	 583	 595	 595	
	 B 589	 589	 598	 598	 438	 438	 440	 440	 426	 426	 450	 450	
	 C 599	 599	 585	 585	 427	 427	 430	 430	 584	 584	 425	 425	
	 D Water	 Water	
	 	 	 	 	 	 	 	 	 	
TIMP3	 E 432	 432	 441	 441	 428	 428	 597	 597	 583	 583	 595	 595	
	 F 589	 589	 598	 598	 438	 438	 440	 440	 426	 426	 450	 450	
	 G 599	 599	 585	 585	 427	 427	 430	 430	 584	 584	 425	 425	
	 H Water	 Water	
	 	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	 	 	 	 	
	 Cq Values  
	
	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
Col1A1	 A 17.8	 18.0	 17.4	 17.5	 18.5	 18.8	 19.4	 19.8	 19.6	 19.7	 22.7	 22.8	
	 B 19.4	 19.7	 19.9	 20.1	 20.9	 21.0	 15.8	 16.0	 18.3	 18.4	 15.9	 16.0	
	 C 17.6	 17.8	 21.5	 21.5	 16.4	 16.3	 15.9	 16.2	 20.2	 20.0	 19.8	 20.0	
	 D 33.6	 40.0	
	 	 	 	 	 	 	 	 	 	
TIMP3	 E 26.3	 25.9	 24.2	 24.2	 22.5	 22.6	 28.1	 28.6	 26.9	 27.1	 31.0	 32.5	
	 F 24.9	 25.2	 26.5	 27.3	 28.8	 28.2	 23.7	 23.8	 25.6	 25.7	 35.9	 25.4	
	 G 24.0	 24.3	 25.5	 25.4	 23.2	 23.3	 22.9	 22.8	 26.8	 26.8	 25.2	 25.2	
	 H 40.0	 40.0	
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D. Sp7 and Msx2 Plate Layout with Cq Values and Melting Points  
 
 Plate Layout with sample number 
Sp7	
	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
 A 432	 432	 441	 441	 428	 428	 597	 597	 583	 583	 595	 595	
 B 589	 589	 598	 598	 438	 438	 440	 440	 426	 426	 450	 450	
 C 599	 599	 585	 585	 427	 427	 430	 430	 584	 584	 425	 425	
	 D Water	 Water	
	 	 	 	 	 	 	 	 	 	
MSX2	 E 432	 432	 441	 441	 428	 428	 597	 597	 583	 583	 595	 595	
 F 589	 589	 598	 598	 438	 438	 440	 440	 426	 426	 450	 450	
 G 599	 599	 585	 585	 427	 427	 430	 430	 584	 584	 425	 425	
 H Water	 Water	




	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
Col1A1	 A 78.2	 78.0	 78.1	 78.0	 78.2	 78.1	 78.1	 78.1	 77.9	 77.8	 78.1	 78.1	
	 B 78.3	 78.1	 78.1	 78.1	 79.3	 79.3	 78.2	 78.2	 78.2	 78.2	 78.3	 78.4	
	 C 78.3	 78.3	 78.1	 78.2	 78.1	 78.3	 78.3	 78.2	 78.2	 78.2	 78.2	 78.3	
	 D 72.3	 60.9	
	 	 	 	 	 	 	 	 	 	
TIMP3	 E 77.1	 77.3	 77.3	 77.4	 77.4	 77.4	 77.5	 77.4	 77.3	 77.2	 77.4	 77.4	
	 F 77.4	 77.4	 77.4	 77.3	 78.5	 78.4	 77.5	 77.5	 77.5	 77.4	 69.5	 77.4	
	 G 77.4	 77.3	 77.4	 77.4	 77.4	 77.4	 77.6	 77.6	 77.5	 77.4	 77.6	 77.6	
	 H 60.4	 61.0	




Cq Values  
Sp7	
	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
 A 28.9	 28.8	 27.4	 27.5	 29.8	 29.0	 28.7	 31.0	 31.0	 30.4	 33.1	 34.7	
 B 28.6	 29.5	 30.1	 31.2	 30.6	 31.9	 24.4	 24.4	 29.8	 29.3	 27.4	 27.4	
 C 28.6	 28.8	 30.2	 31.6	 27.5	 27.5	 27.4	 27.4	 30.2	 30.0	 28.7	 28.8	
 D 40.0	 40.0	
	 	 	 	 	 	 	 	 	 	
MSX2	 E 29.7	 28.8	 27.9	 28.3	 27.5	 27.7	 26.0	 25.8	 26.5	 26.9	 30.4	 32.9	
 F 27.3	 27.6	 25.0	 25.0	 29.8	 30.0	 22.5	 22.5	 28.2	 27.5	 28.5	 28.6	
 G 25.7	 25.5	 24.9	 24.8	 24.0	 24.1	 26.6	 26.5	 26.7	 26.5	 25.8	 25.8	
 H 33.9	 33.5	
	 	 	 	 	 	 	 	 	 	
              
              
 Melting Point 
Sp7	
	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
 A 82.2	 82.0	 82.1	 82.0	 82.1	 82.4	 82.2	 82.3	 82.0	 82.1	 82.3	 82.3	
 B 82.2	 82.0	 82.1	 82.1	 83.1	 83.0	 82.3	 82.3	 81.1	 82.1	 82.4	 82.1	
 C 82.4	 82.3	 82.5	 82.0	 82.2	 82.2	 82.3	 82.3	 82.2	 82.2	 82.5	 82.5	
 D 62.1	 60.8	
	 	 	 	 	 	 	 	 	 	
MSX2	 E 79.3	 79.5	 79.5	 79.5	 79.6	 79.7	 79.6	 79.6	 79.6	 79.6	 73.2	 73.8	
 F 79.7	 79.5	 79.7	 79.6	 79.4	 79.4	 79.7	 79.8	 79.5	 79.6	 79.7	 79.6	
 G 79.7	 79.7	 79.6	 79.7	 79.8	 79.7	 79.8	 79.8	 79.8	 79.7	 79.7	 79.7	
 H 73.9	 73.8	
	 	 	 	 	 	 	 	 	 	
	
	
 
 
 
 
	
